{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T05:21:22Z","timestamp":1787462482150,"version":"build-2736575974"},"reference-count":362,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003126","name":"Opetus- ja Kulttuuriministeri\u00f6","doi-asserted-by":"publisher","award":["OPH-4300-2024"],"award-info":[{"award-number":["OPH-4300-2024"]}],"id":[{"id":"10.13039\/501100003126","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["337120"],"award-info":[{"award-number":["337120"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007797","name":"University of Helsinki","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007797","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sports Med"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s40279-026-02447-y","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T07:36:55Z","timestamp":1779349015000},"page":"2089-2119","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Angiogenic Doping: Plausible Yet Difficult to Detect"],"prefix":"10.1007","volume":"56","author":[{"given":"Sofie","family":"Lehto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Setareh","family":"Sima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaana","family":"K\u00fcnnapuu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergei","family":"Iljukov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2890-7790","authenticated-orcid":false,"given":"Michael","family":"Jeltsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,21]]},"reference":[{"key":"2447_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fspor.2022.986875","volume":"4","author":"B Krumm","year":"2022","unstructured":"Krumm B, Botr\u00e8 F, Saugy JJ, Faiss R. Future opportunities for the Athlete Biological Passport. Front Sports Act Living. 2022;4:986875. https:\/\/doi.org\/10.3389\/fspor.2022.986875.","journal-title":"Front Sports Act Living"},{"key":"2447_CR2","doi-asserted-by":"publisher","first-page":"155","DOI":"10.5604\/20831862.1059606","volume":"30","author":"A Pokrywka","year":"2013","unstructured":"Pokrywka A, Kaliszewski P, Majorczyk E, Zembro\u0144-\u0141acny A. Genes in sport and doping. Biol Sport. 2013;30:155\u201361. https:\/\/doi.org\/10.5604\/20831862.1059606.","journal-title":"Biol Sport"},{"key":"2447_CR3","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/bcp.12010","volume":"76","author":"D Gould","year":"2013","unstructured":"Gould D. Gene doping: gene delivery for Olympic victory. Br J Clin Pharmacol. 2013;76:292\u20138. https:\/\/doi.org\/10.1111\/bcp.12010.","journal-title":"Br J Clin Pharmacol"},{"key":"2447_CR4","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1002\/dta.2198","volume":"9","author":"T Wilkin","year":"2017","unstructured":"Wilkin T, Baoutina A, Hamilton N. Equine performance genes and the future of doping in horseracing. Drug Test Anal. 2017;9:1456\u201371. https:\/\/doi.org\/10.1002\/dta.2198.","journal-title":"Drug Test Anal"},{"key":"2447_CR5","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1111\/evj.14418","volume":"57","author":"M Puchalska","year":"2025","unstructured":"Puchalska M, Witkowska-Pi\u0142aszewicz O. Gene doping in horse racing and equine sports: current landscape and future perspectives. Equine Vet J. 2025;57:312\u201324. https:\/\/doi.org\/10.1111\/evj.14418.","journal-title":"Equine Vet J"},{"key":"2447_CR6","unstructured":"IOC, WADA. Olympic Movement Anti-Doping Code 1999, Appendix A. IOC, WADA; 2003. https:\/\/web.archive.org\/web\/20031011110933\/http:\/\/www.wada-ama.org\/docs\/web\/research_science\/prohibited_substances\/prohibited%20classes%20of%20substances%20and%20prohibited%20methods%202003.pdf"},{"key":"2447_CR7","unstructured":"Philostratus LF. De Gymnastica. 200 AD. https:\/\/www.perseus.tufts.edu\/hopper\/text?doc=Perseus:text:2008.01.0600"},{"key":"2447_CR8","doi-asserted-by":"publisher","first-page":"357","DOI":"10.2165\/00007256-200434060-00002","volume":"34","author":"M Unal","year":"2004","unstructured":"Unal M, Ozer Unal D. Gene doping in sports. Sports Med. 2004;34:357\u201362. https:\/\/doi.org\/10.2165\/00007256-200434060-00002.","journal-title":"Sports Med"},{"key":"2447_CR9","unstructured":"Hoyt A. Blood Doping Goes Back to the Future. The Atlantic. 2010. https:\/\/www.theatlantic.com\/technology\/archive\/2010\/11\/blood-doping-goes-back-to-the-future\/65508\/. Accessed 30 Jun 2025"},{"key":"2447_CR10","doi-asserted-by":"publisher","first-page":"i40","DOI":"10.1136\/bjsports-2013-092837","volume":"47","author":"RF Chapman","year":"2013","unstructured":"Chapman RF. The individual response to training and competition at altitude. Br J Sports Med. 2013;47:i40\u20134. https:\/\/doi.org\/10.1136\/bjsports-2013-092837.","journal-title":"Br J Sports Med"},{"key":"2447_CR11","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1152\/japplphysiol.01395.2005","volume":"100","author":"B Saltin","year":"2006","unstructured":"Saltin B, Calbet JAL. Point: in health and in a normoxic environment, V\u0307o2 max is limited primarily by cardiac output and locomotor muscle blood flow. J Appl Physiol. 2006;100:744\u20138. https:\/\/doi.org\/10.1152\/japplphysiol.01395.2005.","journal-title":"J Appl Physiol"},{"key":"2447_CR12","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1152\/japplphysiol.01597.2005","volume":"100","author":"DER Warburton","year":"2006","unstructured":"Warburton DER, Gledhill N. Comment on point:counterpoint \u201cin health and in a normoxic environment, V\u0307o2 max is\/is not limited primarily by cardiac output and locomotor muscle blood flow.\u201d J Appl Physiol. 2006;100:1415\u20136. https:\/\/doi.org\/10.1152\/japplphysiol.01597.2005.","journal-title":"J Appl Physiol"},{"key":"2447_CR13","unstructured":"Wikipedia. List of doping cases in cycling. Wikipedia. 2025. https:\/\/en.wikipedia.org\/wiki\/List_of_doping_cases_in_cycling. Accessed 4 Jul 2025"},{"key":"2447_CR14","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1373\/clinchem.2011.162271","volume":"57","author":"P-E Sottas","year":"2011","unstructured":"Sottas P-E, Robinson N, Rabin O, Saugy M. The Athlete Biological Passport. Clin Chem. 2011;57:969\u201376. https:\/\/doi.org\/10.1373\/clinchem.2011.162271.","journal-title":"Clin Chem"},{"key":"2447_CR15","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1002\/dta.406","volume":"4","author":"YO Schumacher","year":"2012","unstructured":"Schumacher YO, Saugy M, Pottgiesser T, Robinson N. Detection of EPO doping and blood doping: the haematological module of the Athlete Biological Passport. Drug Test Anal. 2012;4:846\u201353. https:\/\/doi.org\/10.1002\/dta.406.","journal-title":"Drug Test Anal"},{"key":"2447_CR16","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1152\/japplphysiol.00706.2023","volume":"136","author":"DJ Wakeham","year":"2024","unstructured":"Wakeham DJ, Hearon CM, Levine BD. The effect of chronic habitual exercise on oxygen carrying capacity and blood compartment volumes in older adults. J Appl Physiol. 2024;136:984\u201393. https:\/\/doi.org\/10.1152\/japplphysiol.00706.2023.","journal-title":"J Appl Physiol"},{"key":"2447_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/2046-7648-2-33","volume":"2","author":"JM Otto","year":"2013","unstructured":"Otto JM, Montgomery HE, Richards T. Haemoglobin concentration and mass as determinants of exercise performance and of surgical outcome. Extreme Physiol Med. 2013;2:33. https:\/\/doi.org\/10.1186\/2046-7648-2-33.","journal-title":"Extreme Physiol Med"},{"key":"2447_CR18","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1097\/JES.0b013e3181d4957a","volume":"38","author":"W Schmidt","year":"2010","unstructured":"Schmidt W, Prommer N. Impact of alterations in total hemoglobin mass on V\u02d9O2max. Exerc Sport Sci Rev. 2010;38:68. https:\/\/doi.org\/10.1097\/JES.0b013e3181d4957a.","journal-title":"Exerc Sport Sci Rev"},{"key":"2447_CR19","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1113\/jphysiol.2008.164384","volume":"587","author":"IM Olfert","year":"2009","unstructured":"Olfert IM, Howlett RA, Tang K, Dalton ND, Gu Y, Peterson KL, et al. Muscle-specific VEGF deficiency greatly reduces exercise endurance in mice. J Physiol. 2009;587:1755\u201367. https:\/\/doi.org\/10.1113\/jphysiol.2008.164384.","journal-title":"J Physiol"},{"key":"2447_CR20","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1089\/152581602321080529","volume":"11","author":"ZZ Chong","year":"2002","unstructured":"Chong ZZ, Kang J-Q, Maiese K. Angiogenesis and plasticity: role of erythropoietin in vascular systems. J Hematother Stem Cell Res. 2002;11:863\u201371. https:\/\/doi.org\/10.1089\/152581602321080529.","journal-title":"J Hematother Stem Cell Res"},{"key":"2447_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0156157","volume":"11","author":"CB Malm","year":"2016","unstructured":"Malm CB, Khoo NS, Granlund I, Lindstedt E, Hult A. Autologous doping with cryopreserved red blood cells \u2013 effects on physical performance and detection by multivariate statistics. PLoS ONE. 2016;11:e0156157. https:\/\/doi.org\/10.1371\/journal.pone.0156157.","journal-title":"PLoS ONE"},{"key":"2447_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s40798-019-0204-1","volume":"5","author":"SA Solheim","year":"2019","unstructured":"Solheim SA, Bejder J, Breenfeldt Andersen A, M\u00f8rkeberg J, Nordsborg NB. Autologous blood transfusion enhances exercise performance\u2014strength of the evidence and physiological mechanisms. Sports Med - Open. 2019;5:30. https:\/\/doi.org\/10.1186\/s40798-019-0204-1.","journal-title":"Sports Med - Open"},{"key":"2447_CR23","doi-asserted-by":"publisher","first-page":"556","DOI":"10.3389\/fphys.2020.00556","volume":"11","author":"JL Nielsen","year":"2020","unstructured":"Nielsen JL, Frandsen U, Jensen KY, Prokhorova TA, Dalgaard LB, Bech RD, et al. Skeletal muscle microvascular changes in response to short-term blood flow restricted training\u2014exercise-induced adaptations and signs of perivascular stress. Front Physiol. 2020;11:556. https:\/\/doi.org\/10.3389\/fphys.2020.00556.","journal-title":"Front Physiol"},{"key":"2447_CR24","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/BF00327997","volume":"274","author":"J Wilting","year":"1993","unstructured":"Wilting J, Christ B, Bokeloh M, Weich HA. In vivo effects of vascular endothelial growth factor on the chicken chorioallantoic membrane. Cell Tissue Res. 1993;274:163\u201372.","journal-title":"Cell Tissue Res"},{"key":"2447_CR25","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1006\/dbio.1997.8639","volume":"188","author":"S-J Oh","year":"1997","unstructured":"Oh S-J, Jeltsch MM, Birkenh\u00e4ger R, McCarthy JEG, Weich HA, Christ B, et al. VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane. Dev Biol. 1997;188:96\u2013109. https:\/\/doi.org\/10.1006\/dbio.1997.8639.","journal-title":"Dev Biol"},{"key":"2447_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.895854","volume":"13","author":"K Tona","year":"2022","unstructured":"Tona K, Voemesse K, N\u2019nanl\u00e9 O, Oke OE, Kouame YAE, Bilalissi A, et al. Chicken incubation conditions: role in embryo development, physiology and adaptation to the post-hatch environment. Front Physiol. 2022;13:895854. https:\/\/doi.org\/10.3389\/fphys.2022.895854.","journal-title":"Front Physiol"},{"key":"2447_CR27","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1146\/annurev.ph.58.030196.000321","volume":"58","author":"PD Wagner","year":"1996","unstructured":"Wagner PD. Determinants of maximal oxygen transport and utilization. Annu Rev Physiol. 1996;58:21\u201350. https:\/\/doi.org\/10.1146\/annurev.ph.58.030196.000321.","journal-title":"Annu Rev Physiol"},{"key":"2447_CR28","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1097\/00005768-200001000-00012","volume":"32","author":"DR Bassett Jr","year":"2000","unstructured":"Bassett DR Jr, Howley ET. Limiting factors for maximum oxygen uptake and determinants of endurance performance. Med Sci Sports Exerc. 2000;32:70\u201384. https:\/\/doi.org\/10.1097\/00005768-200001000-00012.","journal-title":"Med Sci Sports Exerc."},{"key":"2447_CR29","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1002\/dta.2773","volume":"12","author":"M Saugy","year":"2020","unstructured":"Saugy M, Leuenberger N. Antidoping: from health tests to the athlete biological passport. Drug Test Anal. 2020;12:621\u20138. https:\/\/doi.org\/10.1002\/dta.2773.","journal-title":"Drug Test Anal"},{"key":"2447_CR30","unstructured":"World Anti-Doping Agency. WADA Prohibited List 2025. World Anti-Doping Agency; 2024. https:\/\/www.wada-ama.org\/sites\/default\/files\/2024-09\/2025list_en_final_clean_12_september_2024.pdf"},{"key":"2447_CR31","doi-asserted-by":"publisher","first-page":"215","DOI":"10.4155\/bio.10.181","volume":"3","author":"RE Simoni","year":"2011","unstructured":"Simoni RE, Scalco FB, de Oliveira MLC, Aquino Neto FR. Plasma volume expanders: use in medicine and detecting misuse in sports. Bioanalysis. 2011;3:215\u201326. https:\/\/doi.org\/10.4155\/bio.10.181.","journal-title":"Bioanalysis"},{"key":"2447_CR32","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s11030-006-9027-3","volume":"10","author":"Y Yamazaki","year":"2006","unstructured":"Yamazaki Y, Morita T. Molecular and functional diversity of vascular endothelial growth factors. Mol Divers. 2006;10:515\u201327. https:\/\/doi.org\/10.1007\/s11030-006-9027-3.","journal-title":"Mol Divers"},{"key":"2447_CR33","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00441-003-0776-3","volume":"314","author":"M Tjwa","year":"2003","unstructured":"Tjwa M, Luttun A, Autiero M, Carmeliet P. VEGF and PlGF: two pleiotropic growth factors with distinct roles in development and homeostasis. Cell Tissue Res. 2003;314:5\u201314. https:\/\/doi.org\/10.1007\/s00441-003-0776-3.","journal-title":"Cell Tissue Res"},{"key":"2447_CR34","doi-asserted-by":"publisher","unstructured":"Baoutina A. Performance enhancement by gene doping. Genet Mol Asp Sport Perform. 2010;373\u201382.\u00a0https:\/\/doi.org\/10.1002\/9781444327335.ch32.","DOI":"10.1002\/9781444327335.ch32"},{"key":"2447_CR35","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1055\/s-2006-923986","volume":"27","author":"HJ Haisma","year":"2006","unstructured":"Haisma HJ, De Hon O. Gene doping. Int J Sports Med. 2006;27:257\u201366. https:\/\/doi.org\/10.1055\/s-2006-923986.","journal-title":"Int J Sports Med"},{"key":"2447_CR36","doi-asserted-by":"publisher","first-page":"62","DOI":"10.2478\/v10038-008-0009-4","volume":"9","author":"K Krych","year":"2008","unstructured":"Krych K, Go\u017adzicka-J\u00f3zef\u00efak A. Doping in sport: new developments. Hum Mov. 2008;9:62\u201375. https:\/\/doi.org\/10.2478\/v10038-008-0009-4.","journal-title":"Hum Mov"},{"key":"2447_CR37","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1590\/s0100-879x2011007500145","volume":"44","author":"RS Oliveira","year":"2011","unstructured":"Oliveira RS, Collares TF, Smith KR, Collares TV, Seixas FK. The use of genes for performance enhancement: doping or therapy? Braz J Med Biol Res. 2011;44:1194\u2013201. https:\/\/doi.org\/10.1590\/s0100-879x2011007500145.","journal-title":"Braz J Med Biol Res"},{"key":"2447_CR38","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1136\/bjsports-2012-091288","volume":"47","author":"T van der Gronde","year":"2013","unstructured":"van der Gronde T, De Hon O, Haisma HJ, Pieters T. Gene doping: an overview and current implications for athletes. Br J Sports Med. 2013;47:670\u20138. https:\/\/doi.org\/10.1136\/bjsports-2012-091288.","journal-title":"Br J Sports Med"},{"key":"2447_CR39","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1242\/dev.125.4.725","volume":"125","author":"K Choi","year":"1998","unstructured":"Choi K, Kennedy M, Kazarov A, Papadimitriou JC, Keller G. A common precursor for hematopoietic and endothelial cells. Development. 1998;125:725\u201332. https:\/\/doi.org\/10.1242\/dev.125.4.725.","journal-title":"Development"},{"key":"2447_CR40","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/nm0603-669","volume":"9","author":"N Ferrara","year":"2003","unstructured":"Ferrara N, Gerber H-P, LeCouter J. The biology of VEGF and its receptors. Nat Med. 2003;9:669\u201376. https:\/\/doi.org\/10.1038\/nm0603-669.","journal-title":"Nat Med"},{"key":"2447_CR41","doi-asserted-by":"publisher","first-page":"5141","DOI":"10.1073\/pnas.94.10.5141","volume":"94","author":"A Eichmann","year":"1997","unstructured":"Eichmann A, Corbel C, Nataf V, Vaigot P, Br\u00e9ant C, Le Douarin NM. Ligand-dependent development of the endothelial and hemopoietic lineages from embryonic mesodermal cells expressing vascular endothelial growth factor receptor\u20092. Proc Natl Acad Sci U S A. 1997;94:5141\u20136. https:\/\/doi.org\/10.1073\/pnas.94.10.5141.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2447_CR42","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/380439a0","volume":"380","author":"N Ferrara","year":"1996","unstructured":"Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O\u2019Shea KS, et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature. 1996;380:439\u201342. https:\/\/doi.org\/10.1038\/380439a0.","journal-title":"Nature"},{"key":"2447_CR43","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/380435a0","volume":"380","author":"P Carmeliet","year":"1996","unstructured":"Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature. 1996;380:435\u20139. https:\/\/doi.org\/10.1038\/380435a0.","journal-title":"Nature"},{"key":"2447_CR44","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1182\/blood.2020005699","volume":"136","author":"S Fang","year":"2020","unstructured":"Fang S, Chen S, Nurmi H, Lepp\u00e4nen V-M, Jeltsch M, Scadden D, et al. VEGF-C protects the integrity of the bone marrow perivascular niche in mice. Blood. 2020;136:1871\u201383. https:\/\/doi.org\/10.1182\/blood.2020005699.","journal-title":"Blood"},{"key":"2447_CR45","doi-asserted-by":"publisher","first-page":"7037","DOI":"10.1038\/s41598-019-43185-8","volume":"9","author":"K Sekiguchi","year":"2019","unstructured":"Sekiguchi K, Ito Y, Hattori K, Inoue T, Hosono K, Honda M, et al. VEGF receptor 1-expressing macrophages recruited from bone marrow enhances angiogenesis in endometrial tissues. Sci Rep. 2019;9:7037. https:\/\/doi.org\/10.1038\/s41598-019-43185-8.","journal-title":"Sci Rep"},{"key":"2447_CR46","doi-asserted-by":"publisher","first-page":"3829","DOI":"10.1242\/dev.122.12.3829","volume":"122","author":"E Kukk","year":"1996","unstructured":"Kukk E, Lymboussaki A, Taira S, Kaipainen A, Jeltsch M, Joukov V, et al. VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular. Development. 1996;122:3829\u2013337. https:\/\/doi.org\/10.1242\/dev.122.12.3829.","journal-title":"Development."},{"key":"2447_CR47","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1126\/science.276.5317.1423","volume":"276","author":"M Jeltsch","year":"1997","unstructured":"Jeltsch M, Kaipainen A, Joukov V, Meng X, Lakso M, Rauvala H, et al. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science. 1997;276:1423\u20135. https:\/\/doi.org\/10.1126\/science.276.5317.1423.","journal-title":"Science"},{"key":"2447_CR48","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/ni1013","volume":"5","author":"MJ Karkkainen","year":"2004","unstructured":"Karkkainen MJ, Haiko P, Sainio K, Partanen J, Taipale J, Petrova TV, et al. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat Immunol. 2004;5:74\u201380. https:\/\/doi.org\/10.1038\/ni1013.","journal-title":"Nat Immunol"},{"key":"2447_CR49","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1093\/emboj\/20.4.672","volume":"20","author":"SJ Mandriota","year":"2001","unstructured":"Mandriota SJ, Jussila L, Jeltsch M, Compagni A, Baetens D, Prevo R. Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J. 2001;20:672\u201382. https:\/\/doi.org\/10.1093\/emboj\/20.4.672.","journal-title":"EMBO J"},{"key":"2447_CR50","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/84643","volume":"7","author":"M Skobe","year":"2001","unstructured":"Skobe M, Hawighorst T, Jackson DG, Prevo R, Janes L, Velasco P, et al. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med. 2001;7:192\u20138. https:\/\/doi.org\/10.1038\/84643.","journal-title":"Nat Med"},{"key":"2447_CR51","unstructured":"Karpanen T, Egeblad M, Karkkainen MJ, Kubo H, Yl\u00e4-Herttuala S, J\u00e4\u00e4ttel\u00e4 M, et al. Vascular Endothelial Growth Factor C Promotes Tumor Lymphangiogenesis and Intralymphatic Tumor Growth. Cancer Res. 2001;61:1786\u201390. https:\/\/cancerres.aacrjournals.org\/content\/61\/5\/1786."},{"key":"2447_CR52","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1096\/fj.04-1592fje","volume":"18","author":"A Saaristo","year":"2004","unstructured":"Saaristo A, Tammela T, Timonen J, Yla-Herttuala S, Tukiainen E, Asko-Seljavaara S, et al. Vascular endothelial growth factor-C gene therapy restores lymphatic flow across incision wounds. FASEB J. 2004;18:1707\u20139. https:\/\/doi.org\/10.1096\/fj.04-1592fje.","journal-title":"FASEB J"},{"key":"2447_CR53","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1126\/science.6823562","volume":"219","author":"DR Senger","year":"1983","unstructured":"Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science. 1983;219:983\u20135. https:\/\/doi.org\/10.1126\/science.6823562.","journal-title":"Science"},{"key":"2447_CR54","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1126\/science.2479986","volume":"246","author":"DW Leung","year":"1989","unstructured":"Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science. 1989;246:1306\u20139. https:\/\/doi.org\/10.1126\/science.2479986.","journal-title":"Science"},{"key":"2447_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/biology10020167","volume":"10","author":"J K\u00fcnnapuu","year":"2021","unstructured":"K\u00fcnnapuu J, Bokharaie H, Jeltsch M. Proteolytic cleavages in the VEGF family: generating diversity among angiogenic VEGFs, essential for the activation of lymphangiogenic VEGFs. Biology. 2021;10:167. https:\/\/doi.org\/10.3390\/biology10020167.","journal-title":"Biology"},{"key":"2447_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-025-02249-0","volume":"10","author":"C Lee","year":"2025","unstructured":"Lee C, Kim M-J, Kumar A, Lee H-W, Yang Y, Kim Y. Vascular endothelial growth factor signaling in health and disease: from molecular mechanisms to therapeutic perspectives. Signal Transduct Target Ther. 2025;10:170. https:\/\/doi.org\/10.1038\/s41392-025-02249-0.","journal-title":"Signal Transduct Target Ther"},{"key":"2447_CR57","doi-asserted-by":"publisher","first-page":"9267","DOI":"10.1073\/pnas.88.20.9267","volume":"88","author":"D Maglione","year":"1991","unstructured":"Maglione D, Guerriero V, Viglietto G, Delli-Bovi P, Persico MG. Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci U S A. 1991;88:9267\u201371. https:\/\/doi.org\/10.1073\/pnas.88.20.9267.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2447_CR58","doi-asserted-by":"publisher","DOI":"10.1177\/1753495X251327462","author":"RA Gladstone","year":"2025","unstructured":"Gladstone RA, Snelgrove JW, McLaughlin K, Hobson SR, Windrim RC, Melamed N, et al. Placental growth factor (PlGF) and soluble fms-like tyrosine kinase-1 (sFlt1): powerful new tools to guide obstetric and medical care in pregnancy. Obstet Med. 2025. https:\/\/doi.org\/10.1177\/1753495X251327462.","journal-title":"Obstet Med"},{"key":"2447_CR59","doi-asserted-by":"publisher","first-page":"2576","DOI":"10.1073\/pnas.93.6.2576","volume":"93","author":"B Olofsson","year":"1996","unstructured":"Olofsson B, Pajusola K, Kaipainen A, von Euler G, Joukov V, Saksela O, et al. Vascular endothelial growth factor B, a novel growth factor for endothelial cells. Proc Natl Acad Sci U S A. 1996;93:2576\u201381. https:\/\/doi.org\/10.1073\/pnas.93.6.2576.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"2447_CR60","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/j.1460-2075.1996.tb00359.x","volume":"15","author":"V Joukov","year":"1996","unstructured":"Joukov V, Pajusola K, Kaipainen A, Chilov D, Lahtinen I, Kukk E, et al. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J. 1996;15(2):290\u20138.","journal-title":"EMBO J"},{"key":"2447_CR61","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1073\/pnas.93.5.1988","volume":"93","author":"J Lee","year":"1996","unstructured":"Lee J, Gray A, Yuan J, Luoh SM, Avraham H, Wood WI. Vascular endothelial growth factor-related protein: a ligand and specific activator of the tyrosine kinase receptor Flt4. Proc Natl Acad Sci U S A. 1996;93:1988\u201392. https:\/\/doi.org\/10.1073\/pnas.93.5.1988.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2447_CR62","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2025.1527971","volume":"13","author":"KG Kuonqui","year":"2025","unstructured":"Kuonqui KG, Campbell A-C, Pollack BL, Shin J, Sarker A, Brown S, et al. Regulation of VEGFR3 signaling in lymphatic endothelial cells. Front Cell Dev Biol. 2025;13:1527971. https:\/\/doi.org\/10.3389\/fcell.2025.1527971.","journal-title":"Front Cell Dev Biol"},{"key":"2447_CR63","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2018.00007","volume":"6","author":"K Rauniyar","year":"2018","unstructured":"Rauniyar K, Jha SK, Jeltsch M. Biology of Vascular Endothelial Growth Factor C in the morphogenesis of lymphatic vessels. Front Bioeng Biotechnol. 2018;6:7. https:\/\/doi.org\/10.3389\/fbioe.2018.00007.","journal-title":"Front Bioeng Biotechnol"},{"key":"2447_CR64","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1073\/pnas.95.2.548","volume":"95","author":"MG Achen","year":"1998","unstructured":"Achen MG, Jeltsch M, Kukk E, M\u00e4kinen T, Vitali A, Wilks AF, et al. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). Proc Natl Acad Sci U S A. 1998;95:548\u201353. https:\/\/doi.org\/10.1073\/pnas.95.2.548.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2447_CR65","doi-asserted-by":"publisher","first-page":"11675","DOI":"10.1073\/pnas.93.21.11675","volume":"93","author":"M Orlandini","year":"1996","unstructured":"Orlandini M, Marconcini L, Ferruzzi R, Oliviero S. Identification of a c-fos-induced gene that is related to the platelet-derived growth factor\/vascular endothelial growth factor family. Proc Natl Acad Sci U S A. 1996;93:11675\u201380. https:\/\/doi.org\/10.1073\/pnas.93.21.11675.","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2447_CR66","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1006\/geno.1997.4774","volume":"42","author":"Y Yamada","year":"1997","unstructured":"Yamada Y, Nezu J, Shimane M, Hirata Y. Molecular cloning of a novel vascular endothelial growth factor, VEGF-D. Genomics. 1997;42:483\u20138. https:\/\/doi.org\/10.1006\/geno.1997.4774.","journal-title":"Genomics"},{"key":"2447_CR67","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241713317","volume":"24","author":"SMZ Bokhari","year":"2023","unstructured":"Bokhari SMZ, Hamar P. Vascular endothelial growth factor-D (VEGF-D): an angiogenesis bypass in malignant tumors. Int J Mol Sci. 2023;24:13317. https:\/\/doi.org\/10.3390\/ijms241713317.","journal-title":"Int J Mol Sci"},{"key":"2447_CR68","doi-asserted-by":"publisher","DOI":"10.3390\/biom8010001","author":"SA Stacker","year":"2018","unstructured":"Stacker SA, Achen MG. Emerging roles for VEGF-D in human disease. Biomolecules. 2018. https:\/\/doi.org\/10.3390\/biom8010001.","journal-title":"Biomolecules"},{"key":"2447_CR69","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1128\/JVI.68.1.84-92.1994","volume":"68","author":"DJ Lyttle","year":"1994","unstructured":"Lyttle DJ, Fraser KM, Fleming SB, Mercer AA, Robinson AJ. Homologs of vascular endothelial growth factor are encoded by the poxvirus orf virus. J Virol. 1994;68:84\u201392. https:\/\/doi.org\/10.1128\/JVI.68.1.84-92.1994.","journal-title":"J Virol"},{"key":"2447_CR70","doi-asserted-by":"publisher","first-page":"11796","DOI":"10.1021\/bi990562z","volume":"38","author":"Y Komori","year":"1999","unstructured":"Komori Y, Nikai T, Taniguchi K, Masuda K, Sugihara H. Vascular endothelial growth factor VEGF-like heparin-binding protein from the venom of Vipera aspis (Aspic viper). Biochemistry. 1999;38:11796\u2013803. https:\/\/doi.org\/10.1021\/bi990562z.","journal-title":"Biochemistry"},{"key":"2447_CR71","doi-asserted-by":"publisher","first-page":"9885","DOI":"10.1074\/jbc.M809071200","volume":"284","author":"Y Yamazaki","year":"2009","unstructured":"Yamazaki Y, Matsunaga Y, Tokunaga Y, Obayashi S, Saito M, Morita T. Snake venom vascular endothelial growth factors (VEGF-Fs) exclusively vary their structures and functions among species. J Biol Chem. 2009;284:9885\u201391. https:\/\/doi.org\/10.1074\/jbc.M809071200.","journal-title":"J Biol Chem"},{"key":"2447_CR72","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1084\/jem.20021244","volume":"196","author":"JA Nagy","year":"2002","unstructured":"Nagy JA, Vasile E, Feng D, Sundberg C, Brown LF, Detmar MJ, et al. Vascular Permeability Factor\/Vascular Endothelial Growth Factor induces lymphangiogenesis as well as angiogenesis. J Exp Med. 2002;196:1497\u2013506. https:\/\/doi.org\/10.1084\/jem.20021244.","journal-title":"J Exp Med"},{"key":"2447_CR73","doi-asserted-by":"publisher","first-page":"3158","DOI":"10.1182\/blood-2007-01-066811","volume":"110","author":"C Halin","year":"2007","unstructured":"Halin C, Tobler NE, Vigl B, Brown LF, Detmar M. VEGF-A produced by chronically inflamed tissue induces lymphangiogenesis in draining lymph nodes. Blood. 2007;110:3158\u201367. https:\/\/doi.org\/10.1182\/blood-2007-01-066811.","journal-title":"Blood"},{"key":"2447_CR74","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.2003905","author":"A Anisimov","year":"2013","unstructured":"Anisimov A, Leppanen V-M, Tvorogov D, Zarkada G, Jeltsch M, Holopainen T, et al. The basis for the distinct biological activities of vascular endothelial growth factor receptor-1 ligands. Sci Signal. 2013. https:\/\/doi.org\/10.1126\/scisignal.2003905.","journal-title":"Sci Signal"},{"key":"2447_CR75","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1161\/CIRCULATIONAHA.110.957332","volume":"122","author":"M Bry","year":"2010","unstructured":"Bry M, Kivel\u00e4 R, Holopainen T, Anisimov A, Tammela T, Soronen J, et al. Vascular Endothelial Growth Factor-B acts as a coronary growth factor in transgenic rats without inducing angiogenesis, vascular leak, or inflammation. Circulation. 2010;122:1725\u201333. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.110.957332.","journal-title":"Circulation"},{"key":"2447_CR76","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1161\/ATVBAHA.107.158725","volume":"28","author":"X Li","year":"2008","unstructured":"Li X, Tjwa M, Van Hove I, Enholm B, Neven E, Paavonen K, et al. Reevaluation of the role of VEGF-B suggests a restricted role in the revascularization of the ischemic myocardium. Arterioscler Thromb Vasc Biol. 2008;28:1614\u201320. https:\/\/doi.org\/10.1161\/ATVBAHA.107.158725.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2447_CR77","doi-asserted-by":"publisher","first-page":"3898","DOI":"10.1093\/emboj\/16.13.3898","volume":"16","author":"V Joukov","year":"1997","unstructured":"Joukov V, Sorsa T, Kumar V, Jeltsch M, Claesson-Welsh L, Cao Y, et al. Proteolytic processing regulates receptor specificity and activity of VEGF-C. EMBO J. 1997;16:3898\u2013911. https:\/\/doi.org\/10.1093\/emboj\/16.13.3898.","journal-title":"EMBO J"},{"key":"2447_CR78","doi-asserted-by":"publisher","first-page":"32127","DOI":"10.1074\/jbc.274.45.32127","volume":"274","author":"SA Stacker","year":"1999","unstructured":"Stacker SA, Stenvers K, Caesar C, Vitali A, Domagala T, Nice E, et al. Biosynthesis of Vascular Endothelial Growth Factor-D involves proteolytic processing which generates non-covalent homodimers. J Biol Chem. 1999;274:32127\u201336. https:\/\/doi.org\/10.1074\/jbc.274.45.32127.","journal-title":"J Biol Chem"},{"key":"2447_CR79","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1161\/01.RES.0000073584.46059.E3","volume":"92","author":"TT Rissanen","year":"2003","unstructured":"Rissanen TT, Markkanen JE, Gruchala M, Heikura T, Puranen A, Kettunen MI, et al. VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses. Circ Res. 2003;92:1098\u2013106. https:\/\/doi.org\/10.1161\/01.RES.0000073584.46059.E3.","journal-title":"Circ Res"},{"key":"2447_CR80","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1161\/01.CIR.0000115519.03688.A2","volume":"109","author":"J Rutanen","year":"2004","unstructured":"Rutanen J, Rissanen TT, Markkanen JE, Gruchala M, Silvennoinen P, Kivel\u00e4 A, et al. Adenoviral Catheter-Mediated Intramyocardial Gene Transfer Using the Mature Form of Vascular Endothelial Growth Factor-D Induces Transmural Angiogenesis in Porcine Heart. Circulation. 2004;109:1029\u201335. https:\/\/doi.org\/10.1161\/01.CIR.0000115519.03688.A2.","journal-title":"Circulation"},{"key":"2447_CR81","doi-asserted-by":"publisher","first-page":"6152","DOI":"10.1073\/pnas.0813061106","volume":"106","author":"F Zhang","year":"2009","unstructured":"Zhang F, Tang Z, Hou X, Lennartsson J, Li Y, Koch AW, et al. VEGF-B is dispensable for blood vessel growth but critical for their survival, and VEGF-B targeting inhibits pathological angiogenesis. Proc Natl Acad Sci U S A. 2009;106:6152\u20137. https:\/\/doi.org\/10.1073\/pnas.0813061106.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2447_CR82","doi-asserted-by":"publisher","first-page":"800","DOI":"10.22038\/IJBMS.2018.27211.6814","volume":"21","author":"M Ardakanizade","year":"2018","unstructured":"Ardakanizade M. The effects of mid- and long-term endurance exercise on heart angiogenesis and oxidative stress. Iran J Basic Med Sci. 2018;21:800\u20135. https:\/\/doi.org\/10.22038\/IJBMS.2018.27211.6814.","journal-title":"Iran J Basic Med Sci"},{"key":"2447_CR83","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0077117","volume":"8","author":"CH Lieu","year":"2013","unstructured":"Lieu CH, Tran H, Jiang Z-Q, Mao M, Overman MJ, Lin E, et al. The Association of Alternate VEGF ligands with resistance to anti-VEGF therapy in metastatic colorectal cancer. PLoS ONE. 2013;8:e77117. https:\/\/doi.org\/10.1371\/journal.pone.0077117.","journal-title":"PLoS ONE"},{"key":"2447_CR84","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1093\/annonc\/mdy028","volume":"29","author":"P Carmeliet","year":"2018","unstructured":"Carmeliet P, Li X, Treps L, Conradi L-C, Loges S. RAISEing VEGF-D\u2019s importance as predictive biomarker for ramucirumab in metastatic colorectal cancer patients. Ann Oncol. 2018;29:529\u201332. https:\/\/doi.org\/10.1093\/annonc\/mdy028.","journal-title":"Ann Oncol"},{"key":"2447_CR85","doi-asserted-by":"publisher","first-page":"25646","DOI":"10.1016\/S0021-9258(18)47298-5","volume":"269","author":"JE Park","year":"1994","unstructured":"Park JE, Chen HH, Winer J, Houck KA, Ferrara N. Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1\/KDR. J Biol Chem. 1994;269:25646\u201354.","journal-title":"J Biol Chem"},{"key":"2447_CR86","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1038\/nm731","volume":"8","author":"A Luttun","year":"2002","unstructured":"Luttun A, Tjwa M, Moons L, Wu Y, Angelillo-Scherrer A, Liao F, et al. Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nat Med. 2002;8:831\u201340. https:\/\/doi.org\/10.1038\/nm731.","journal-title":"Nat Med"},{"key":"2447_CR87","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1128\/MCB.25.6.2441-2449.2005","volume":"25","author":"ME Baldwin","year":"2005","unstructured":"Baldwin ME, Halford MM, Roufail S, Williams RA, Hibbs ML, Grail D, et al. Vascular endothelial growth factor D is dispensable for development of the lymphatic system. Mol Cell Biol. 2005;25:2441\u20139. https:\/\/doi.org\/10.1128\/MCB.25.6.2441-2449.2005.","journal-title":"Mol Cell Biol"},{"key":"2447_CR88","doi-asserted-by":"publisher","first-page":"E29","DOI":"10.1161\/01.res.86.2.e29","volume":"86","author":"D Bellomo","year":"2000","unstructured":"Bellomo D, Headrick JP, Silins GU, Paterson CA, Thomas PS, Gartside M, et al. Mice lacking the vascular endothelial growth factor-B gene (Vegfb) have smaller hearts, dysfunctional coronary vasculature, and impaired recovery from cardiac ischemia. Circ Res. 2000;86:E29\u201335. https:\/\/doi.org\/10.1161\/01.res.86.2.e29.","journal-title":"Circ Res."},{"key":"2447_CR89","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1161\/01.CIR.104.3.358","volume":"104","author":"K Aase","year":"2001","unstructured":"Aase K, von Euler G, Li X, Pont\u00e9n A, Thor\u00e9n P, Cao R, et al. Vascular endothelial growth factor-B\u2013deficient mice display an atrial conduction defect. Circulation. 2001;104:358\u201364. https:\/\/doi.org\/10.1161\/01.CIR.104.3.358.","journal-title":"Circulation"},{"key":"2447_CR90","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S0008-6363(02)00440-6","volume":"55","author":"JC Wanstall","year":"2002","unstructured":"Wanstall JC, Gambino A, Jeffery TK, Cahill MM, Bellomo D, Hayward NK, et al. Vascular endothelial growth factor-B-deficient mice show impaired development of hypoxic pulmonary hypertension. Cardiovasc Res. 2002;55:361\u20138. https:\/\/doi.org\/10.1016\/S0008-6363(02)00440-6.","journal-title":"Cardiovasc Res"},{"key":"2447_CR91","doi-asserted-by":"publisher","first-page":"3635","DOI":"10.1016\/j.celrep.2018.05.067","volume":"23","author":"I Apicella","year":"2018","unstructured":"Apicella I, Cicatiello V, Acampora D, Tarallo V, Falco SD. Full functional knockout of placental growth factor by knockin with an inactive variant able to heterodimerize with VEGF-A. Cell Rep. 2018;23:3635\u201346. https:\/\/doi.org\/10.1016\/j.celrep.2018.05.067.","journal-title":"Cell Rep"},{"key":"2447_CR92","first-page":"2943","volume":"50","author":"E Cheung","year":"2009","unstructured":"Cheung E, Myers K, Yancopoulos GD, Lobov IB, Wiegand SJ. Placental growth factor (PlGF) deficient mice show delays in normal retinal vascular development and reduced vascular abnormalities in oxygen-induced retinal ischemia. Invest Ophthalmol Vis Sci. 2009;50:2943.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2447_CR93","doi-asserted-by":"publisher","first-page":"5008","DOI":"10.1172\/JCI99026","volume":"128","author":"JG Parchem","year":"2018","unstructured":"Parchem JG, Kanasaki K, Kanasaki M, Sugimoto H, Xie L, Hamano Y, et al. Loss of placental growth factor ameliorates maternal hypertension and preeclampsia in mice. J Clin Invest. 2018;128:5008\u201317. https:\/\/doi.org\/10.1172\/JCI99026.","journal-title":"J Clin Invest"},{"key":"2447_CR94","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1182\/blood-2002-05-1516","volume":"101","author":"H Oura","year":"2003","unstructured":"Oura H, Bertoncini J, Velasco P, Brown LF, Carmeliet P, Detmar M. A critical role of placental growth factor in the induction of inflammation and edema formation. Blood. 2003;101:560\u20137. https:\/\/doi.org\/10.1182\/blood-2002-05-1516.","journal-title":"Blood"},{"key":"2447_CR95","doi-asserted-by":"publisher","first-page":"6178","DOI":"10.1128\/MCB.18.11.6178","volume":"18","author":"I Huez","year":"1998","unstructured":"Huez I, Cr\u00e9ancier L, Audigier S, Gensac MC, Prats AC, Prats H. Two independent internal ribosome entry sites are involved in translation initiation of vascular endothelial growth factor mRNA. Mol Cell Biol. 1998;18:6178\u201390. https:\/\/doi.org\/10.1128\/MCB.18.11.6178.","journal-title":"Mol Cell Biol"},{"key":"2447_CR96","doi-asserted-by":"publisher","first-page":"3112","DOI":"10.1128\/MCB.18.6.3112","volume":"18","author":"I Stein","year":"1998","unstructured":"Stein I, Itin A, Einat P, Skaliter R, Grossman Z, Keshet E. Translation of vascular endothelial growth factor mRNA by internal ribosome entry: implications for translation under hypoxia. Mol Cell Biol. 1998;18:3112\u20139. https:\/\/doi.org\/10.1128\/MCB.18.6.3112.","journal-title":"Mol Cell Biol"},{"key":"2447_CR97","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.cardiores.2004.09.032","volume":"65","author":"G Pag\u00e8s","year":"2005","unstructured":"Pag\u00e8s G, Pouyss\u00e9gur J. Transcriptional regulation of the Vascular Endothelial Growth Factor gene\u2013a concert of activating factors. Cardiovasc Res. 2005;65:564\u201373. https:\/\/doi.org\/10.1016\/j.cardiores.2004.09.032.","journal-title":"Cardiovasc Res"},{"key":"2447_CR98","doi-asserted-by":"publisher","first-page":"7997","DOI":"10.1093\/nar\/gkt539","volume":"41","author":"T Arcond\u00e9guy","year":"2013","unstructured":"Arcond\u00e9guy T, Lacazette E, Millevoi S, Prats H, Touriol C. VEGF-A mRNA processing, stability and translation: a paradigm for intricate regulation of gene expression at the post-transcriptional level. Nucleic Acids Res. 2013;41:7997\u20138010. https:\/\/doi.org\/10.1093\/nar\/gkt539.","journal-title":"Nucleic Acids Res"},{"key":"2447_CR99","doi-asserted-by":"publisher","unstructured":"Detmar M, Yeo KT, Nagy JA, Van de Water L, Brown LF, Berse B, et al. Keratinocyte-derived vascular permeability factor (vascular endothelial growth factor) is a potent mitogen for dermal microvascular endothelial cells. J Invest Dermatol. 1995;105:44\u201350. https:\/\/doi.org\/10.1111\/1523-1747.ep12312542","DOI":"10.1111\/1523-1747.ep12312542"},{"key":"2447_CR100","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1084\/jem.176.5.1375","volume":"176","author":"LF Brown","year":"1992","unstructured":"Brown LF, Yeo KT, Berse B, Yeo TK, Senger DR, Dvorak HF, et al. Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. J Exp Med. 1992;176:1375\u20139. https:\/\/doi.org\/10.1084\/jem.176.5.1375.","journal-title":"J Exp Med"},{"key":"2447_CR101","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1152\/japplphysiol.01402.2004","volume":"98","author":"T Gustafsson","year":"2005","unstructured":"Gustafsson T, Ameln H, Fischer H, Sundberg CJ, Timmons JA, Jansson E. VEGF-A splice variants and related receptor expression in human skeletal muscle following submaximal exercise. J Appl Physiol. 2005;98:2137\u201346. https:\/\/doi.org\/10.1152\/japplphysiol.01402.2004.","journal-title":"J Appl Physiol"},{"key":"2447_CR102","doi-asserted-by":"publisher","first-page":"H772","DOI":"10.1152\/ajpheart.2000.279.2.H772","volume":"279","author":"RS Richardson","year":"2000","unstructured":"Richardson RS, Wagner H, Mudaliar SRD, Saucedo E, Henry R, Wagner PD. Exercise adaptation attenuates VEGF gene expression in human skeletal muscle. Am J Physiol-Heart Circ Physiol. 2000;279:H772\u20138. https:\/\/doi.org\/10.1152\/ajpheart.2000.279.2.H772.","journal-title":"Am J Physiol-Heart Circ Physiol."},{"key":"2447_CR103","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.jss.2008.04.023","volume":"153","author":"P Bao","year":"2009","unstructured":"Bao P, Kodra A, Tomic-Canic M, Golinko MS, Ehrlich HP, Brem H. The role of vascular endothelial growth factor in wound healing. J Surg Res. 2009;153:347\u201358. https:\/\/doi.org\/10.1016\/j.jss.2008.04.023.","journal-title":"J Surg Res"},{"key":"2447_CR104","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1172\/JCI11317","volume":"107","author":"K Yano","year":"2001","unstructured":"Yano K, Brown LF, Detmar M. Control of hair growth and follicle size by VEGF-mediated angiogenesis. J Clin Invest. 2001;107:409\u201317. https:\/\/doi.org\/10.1172\/JCI11317.","journal-title":"J Clin Invest."},{"key":"2447_CR105","doi-asserted-by":"publisher","DOI":"10.1530\/rep.0.1230379","author":"N Sugino","year":"2002","unstructured":"Sugino N, Kashida S, Karube-Harada A, Takiguchi S, Kato H. Expression of vascular endothelial growth factor (VEGF) and its receptors in human endometrium throughout the menstrual cycle and in early pregnancy. Reproduction. 2002. https:\/\/doi.org\/10.1530\/rep.0.1230379.","journal-title":"Reproduction"},{"key":"2447_CR106","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/BF03183286","volume":"48","author":"Q Dong","year":"2003","unstructured":"Dong Q, Cheng Z. Functions of VEGF in female reproductive system. Chin Sci Bull. 2003;48:217\u201322. https:\/\/doi.org\/10.1007\/BF03183286.","journal-title":"Chin Sci Bull"},{"key":"2447_CR107","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1161\/01.CIR.98.20.2108","volume":"98","author":"M Inoue","year":"1998","unstructured":"Inoue M, Itoh H, Ueda M, Naruko T, Kojima A, Komatsu R, et al. Vascular Endothelial Growth Factor (VEGF) expression in human coronary atherosclerotic lesions: possible pathophysiological significance of VEGF in progression of atherosclerosis. Circulation. 1998;98:2108\u201316. https:\/\/doi.org\/10.1161\/01.CIR.98.20.2108.","journal-title":"Circulation"},{"key":"2447_CR108","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1084\/jem.20060375","volume":"203","author":"K Yano","year":"2006","unstructured":"Yano K, Liaw PC, Mullington JM, Shih S-C, Okada H, Bodyak N, et al. Vascular endothelial growth factor is an important determinant of sepsis morbidity and mortality. J Exp Med. 2006;203:1447\u201358. https:\/\/doi.org\/10.1084\/jem.20060375.","journal-title":"J Exp Med"},{"key":"2447_CR109","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1053\/j.gastro.2008.09.064","volume":"136","author":"F Scaldaferri","year":"2009","unstructured":"Scaldaferri F, Vetrano S, Sans M, Arena V, Straface G, Stigliano E, et al. VEGF-A links angiogenesis and inflammation in inflammatory bowel disease pathogenesis. Gastroenterology. 2009;136:585-595.e5. https:\/\/doi.org\/10.1053\/j.gastro.2008.09.064.","journal-title":"Gastroenterology"},{"key":"2447_CR110","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s00432-024-05714-5","volume":"150","author":"Y Kang","year":"2024","unstructured":"Kang Y, Li H, Liu Y, Li Z. Regulation of VEGF-A expression and VEGF-A-targeted therapy in malignant tumors. J Cancer Res Clin Oncol. 2024;150:221. https:\/\/doi.org\/10.1007\/s00432-024-05714-5.","journal-title":"J Cancer Res Clin Oncol"},{"key":"2447_CR111","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s11481-014-9531-7","volume":"9","author":"S Ramakrishnan","year":"2014","unstructured":"Ramakrishnan S, Anand V, Roy S. Vascular Endothelial growth factor signaling in hypoxia and Inflammation. J Neuroimmune Pharmacol. 2014;9:142\u201360. https:\/\/doi.org\/10.1007\/s11481-014-9531-7.","journal-title":"J Neuroimmune Pharmacol"},{"key":"2447_CR112","doi-asserted-by":"publisher","first-page":"8413","DOI":"10.1074\/jbc.273.14.8413","volume":"273","author":"A Ristim\u00e4ki","year":"1998","unstructured":"Ristim\u00e4ki A, Narko K, Enholm B, Joukov V, Alitalo K. Proinflammatory cytokines regulate expression of the lymphatic endothelial mitogen vascular endothelial growth factor-C. J Biol Chem. 1998;273:8413\u20138. https:\/\/doi.org\/10.1074\/jbc.273.14.8413.","journal-title":"J Biol Chem"},{"key":"2447_CR113","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.celrep.2013.12.011","volume":"6","author":"F Morfoisse","year":"2014","unstructured":"Morfoisse F, Kuchnio A, Frainay C, Gomez-Brouchet A, Delisle M-B, Marzi S, et al. Hypoxia induces VEGF-C expression in metastatic tumor cells via a HIF-1\u03b1-independent translation-mediated mechanism. Cell Rep. 2014;6:155\u201367. https:\/\/doi.org\/10.1016\/j.celrep.2013.12.011.","journal-title":"Cell Rep"},{"key":"2447_CR114","first-page":"3003","volume":"25","author":"K Okada","year":"2005","unstructured":"Okada K, Osaki M, Araki K, Ishiguro K, Ito H, Ohgi S. Expression of Hypoxia-inducible Factor (HIF-1\u03b1), VEGF-C and VEGF-D in non-invasive and invasive breast ductal carcinomas. Anticancer Res. 2005;25:3003\u20139.","journal-title":"Anticancer Res"},{"key":"2447_CR115","doi-asserted-by":"publisher","first-page":"4604","DOI":"10.1128\/MCB.16.9.4604","volume":"16","author":"JA Forsythe","year":"1996","unstructured":"Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, Koos RD, et al. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol. 1996;16:4604\u201313. https:\/\/doi.org\/10.1128\/MCB.16.9.4604.","journal-title":"Mol Cell Biol"},{"key":"2447_CR116","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1203\/00006450-200105000-00002","volume":"49","author":"GL Semenza","year":"2001","unstructured":"Semenza GL. Hypoxia-Inducible Factor 1: control of oxygen homeostasis in health and disease. Pediatr Res. 2001;49:614\u20137. https:\/\/doi.org\/10.1203\/00006450-200105000-00002.","journal-title":"Pediatr Res"},{"key":"2447_CR117","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/359843a0","volume":"359","author":"D Shweiki","year":"1992","unstructured":"Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature. 1992;359:843\u20135. https:\/\/doi.org\/10.1038\/359843a0.","journal-title":"Nature"},{"key":"2447_CR118","doi-asserted-by":"publisher","first-page":"13333","DOI":"10.1074\/jbc.270.22.13333","volume":"270","author":"AP Levy","year":"1995","unstructured":"Levy AP, Levy NS, Wegner S, Goldberg MA. Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J Biol Chem. 1995;270:13333\u201340. https:\/\/doi.org\/10.1074\/jbc.270.22.13333.","journal-title":"J Biol Chem"},{"key":"2447_CR119","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1161\/01.res.77.3.638","volume":"77","author":"Y Liu","year":"1995","unstructured":"Liu Y, Cox SR, Morita T, Kourembanas S. Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5\u2019 enhancer. Circ Res. 1995;77:638\u201343. https:\/\/doi.org\/10.1161\/01.res.77.3.638.","journal-title":"Circ Res"},{"key":"2447_CR120","doi-asserted-by":"publisher","first-page":"19575","DOI":"10.1074\/jbc.R200030200","volume":"278","author":"LE Huang","year":"2003","unstructured":"Huang LE, Bunn HF. Hypoxia-inducible factor and its biomedical relevance. J Biol Chem. 2003;278:19575\u20138. https:\/\/doi.org\/10.1074\/jbc.R200030200.","journal-title":"J Biol Chem"},{"key":"2447_CR121","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.ceb.2009.08.005","volume":"21","author":"RB Hamanaka","year":"2009","unstructured":"Hamanaka RB, Chandel NS. Mitochondrial reactive oxygen species regulate hypoxic signaling. Curr Opin Cell Biol. 2009;21:894\u20139. https:\/\/doi.org\/10.1016\/j.ceb.2009.08.005.","journal-title":"Curr Opin Cell Biol"},{"key":"2447_CR122","doi-asserted-by":"publisher","first-page":"26988","DOI":"10.1016\/S0021-9258(18)47116-5","volume":"269","author":"J Waltenberger","year":"1994","unstructured":"Waltenberger J, Claesson-Welsh L, Siegbahn A, Shibuya M, Heldin CH. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J Biol Chem. 1994;269:26988\u201395. https:\/\/doi.org\/10.1016\/S0021-9258(18)47116-5.","journal-title":"J Biol Chem"},{"key":"2447_CR123","doi-asserted-by":"publisher","first-page":"3222","DOI":"10.1074\/jbc.M002016200","volume":"276","author":"H Gille","year":"2001","unstructured":"Gille H, Kowalski J, Li B, LeCouter J, Moffat B, Zioncheck TF, et al. Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2): a reassessment using novel receptor-specific vascular endothelial growth factor mutants. J Biol Chem. 2001;276:3222\u201330. https:\/\/doi.org\/10.1074\/jbc.M002016200.","journal-title":"J Biol Chem"},{"key":"2447_CR124","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1084\/jem.20111343","volume":"209","author":"Z Sun","year":"2012","unstructured":"Sun Z, Li X, Massena S, Kutschera S, Padhan N, Gualandi L, et al. VEGFR2 induces c-Src signaling and vascular permeability in vivo via the adaptor protein TSAd. J Exp Med. 2012;209:1363\u201377. https:\/\/doi.org\/10.1084\/jem.20111343.","journal-title":"J Exp Med"},{"key":"2447_CR125","doi-asserted-by":"publisher","first-page":"9349","DOI":"10.1073\/pnas.95.16.9349","volume":"95","author":"S Hiratsuka","year":"1998","unstructured":"Hiratsuka S, Minowa O, Kuno J, Noda T, Shibuya M. Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice. Proc Natl Acad Sci U S A. 1998;95:9349\u201354. https:\/\/doi.org\/10.1073\/pnas.95.16.9349.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2447_CR126","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1128\/MCB.25.1.346-354.2005","volume":"25","author":"S Hiratsuka","year":"2005","unstructured":"Hiratsuka S, Nakao K, Nakamura K, Katsuki M, Maru Y, Shibuya M. Membrane fixation of vascular endothelial growth factor receptor 1 ligand-binding domain is important for vasculogenesis and angiogenesis in mice. Mol Cell Biol. 2005;25:346\u201354. https:\/\/doi.org\/10.1128\/MCB.25.1.346-354.2005.","journal-title":"Mol Cell Biol"},{"key":"2447_CR127","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1042\/CS20040370","volume":"109","author":"H Takahashi","year":"2005","unstructured":"Takahashi H, Shibuya M. The vascular endothelial growth factor (VEGF)\/VEGF receptor system and its role under physiological and pathological conditions. Clin Sci Lond Engl 1979. 2005;109:227\u201341. https:\/\/doi.org\/10.1042\/CS20040370.","journal-title":"Clin Sci Lond Engl 1979"},{"key":"2447_CR128","doi-asserted-by":"publisher","first-page":"3566","DOI":"10.1073\/pnas.92.8.3566","volume":"92","author":"A Kaipainen","year":"1995","unstructured":"Kaipainen A, Korhonen J, Mustonen T, van Hinsbergh VW, Fang GH, Dumont D, et al. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci U S A. 1995;92:3566\u201370. https:\/\/doi.org\/10.1073\/pnas.92.8.3566.","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2447_CR129","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.exer.2004.06.028","volume":"79","author":"P Hamrah","year":"2004","unstructured":"Hamrah P, Chen L, Cursiefen C, Zhang Q, Joyce NC, Dana MR. Expression of vascular endothelial growth factor receptor-3 (VEGFR-3) on monocytic bone marrow-derived cells in the conjunctiva. Exp Eye Res. 2004;79:553\u201361. https:\/\/doi.org\/10.1016\/j.exer.2004.06.028.","journal-title":"Exp Eye Res"},{"key":"2447_CR130","doi-asserted-by":"publisher","first-page":"469","DOI":"10.5483\/bmbrep.2006.39.5.469","volume":"39","author":"M Shibuya","year":"2006","unstructured":"Shibuya M. Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis. J Biochem Mol Biol. 2006;39:469\u201378. https:\/\/doi.org\/10.5483\/bmbrep.2006.39.5.469.","journal-title":"J Biochem Mol Biol"},{"key":"2447_CR131","doi-asserted-by":"publisher","first-page":"3699","DOI":"10.1161\/01.CIR.0000143626.16576.51","volume":"110","author":"G Nowak","year":"2004","unstructured":"Nowak G, Karrar A, Holm\u00e9n C, Nava S, Uzunel M, Hultenby K, et al. Expression of vascular endothelial growth factor receptor-2 or tie-2 on peripheral blood cells defines functionally competent cell populations capable of reendothelialization. Circulation. 2004;110:3699\u2013707. https:\/\/doi.org\/10.1161\/01.CIR.0000143626.16576.51.","journal-title":"Circulation"},{"key":"2447_CR132","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1002\/jcp.1121","volume":"188","author":"A Ishida","year":"2001","unstructured":"Ishida A, Murray J, Saito Y, Kanthou C, Benzakour O, Shibuya M, et al. Expression of vascular endothelial growth factor receptors in smooth muscle cells. J Cell Physiol. 2001;188:359\u201368. https:\/\/doi.org\/10.1002\/jcp.1121.","journal-title":"J Cell Physiol"},{"key":"2447_CR133","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-02907-6","volume":"7","author":"XH Liao","year":"2017","unstructured":"Liao XH, Xiang Y, Li H, Zheng DL, Xu Y, Xi Yu C, et al. VEGF-A stimulates STAT3 activity via nitrosylation of Myocardin to regulate the expression of vascular smooth muscle cell differentiation markers. Sci Rep. 2017;7:2660. https:\/\/doi.org\/10.1038\/s41598-017-02907-6.","journal-title":"Sci Rep"},{"key":"2447_CR134","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1007\/s00018-013-1279-3","volume":"70","author":"IM Wittko-Schneider","year":"2013","unstructured":"Wittko-Schneider IM, Schneider FT, Plate KH. Brain homeostasis: VEGF receptor 1 and 2\u2014two unequal brothers in mind. Cell Mol Life Sci. 2013;70:1705\u201325. https:\/\/doi.org\/10.1007\/s00018-013-1279-3.","journal-title":"Cell Mol Life Sci"},{"key":"2447_CR135","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jchemneu.2011.06.001","volume":"42","author":"Y Hou","year":"2011","unstructured":"Hou Y, Shin Y-J, Han EJ, Choi J-S, Park J-M, Cha J-H, et al. Distribution of vascular endothelial growth factor receptor-3\/Flt4 mRNA in adult rat central nervous system. J Chem Neuroanat. 2011;42:56\u201364. https:\/\/doi.org\/10.1016\/j.jchemneu.2011.06.001.","journal-title":"J Chem Neuroanat"},{"key":"2447_CR136","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.neuroscience.2015.04.063","volume":"303","author":"MC Ward","year":"2015","unstructured":"Ward MC, Cunningham AM. Developmental expression of vascular endothelial growth factor receptor 3 and vascular endothelial growth factor C in forebrain. Neuroscience. 2015;303:544\u201357. https:\/\/doi.org\/10.1016\/j.neuroscience.2015.04.063.","journal-title":"Neuroscience"},{"key":"2447_CR137","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1161\/CIRCULATIONAHA.113.002779","volume":"129","author":"M Jeltsch","year":"2014","unstructured":"Jeltsch M, Jha SK, Tvorogov D, Anisimov A, Lepp\u00e4nen V-M, Holopainen T, et al. CCBE1 enhances lymphangiogenesis via A Disintegrin and Metalloprotease With Thrombospondin Motifs-3\u2013mediated vascular endothelial growth factor-C activation. Circulation. 2014;129:1962\u201371. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.113.002779.","journal-title":"Circulation"},{"key":"2447_CR138","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16552-7","volume":"11","author":"G Wang","year":"2020","unstructured":"Wang G, Muhl L, Padberg Y, Dupont L, Peterson-Maduro J, Stehling M, et al. Specific fibroblast subpopulations and neuronal structures provide local sources of Vegfc-processing components during zebrafish lymphangiogenesis. Nat Commun. 2020;11:2724. https:\/\/doi.org\/10.1038\/s41467-020-16552-7.","journal-title":"Nat Commun"},{"key":"2447_CR139","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1182\/blood-2010-08-301549","volume":"117","author":"V-M Leppanen","year":"2011","unstructured":"Leppanen V-M, Jeltsch M, Anisimov A, Tvorogov D, Aho K, Kalkkinen N, et al. Structural determinants of vascular endothelial growth factor-D receptor binding and specificity. Blood. 2011;117:1507\u201315. https:\/\/doi.org\/10.1182\/blood-2010-08-301549.","journal-title":"Blood"},{"key":"2447_CR140","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.44478","volume":"8","author":"SK Jha","year":"2019","unstructured":"Jha SK, Rauniyar K, Chronowska E, Mattonet K, Maina EW, Koistinen H, et al. KLK3\/PSA and cathepsin D activate VEGF-C and VEGF-D. Elife. 2019;8:e44478. https:\/\/doi.org\/10.7554\/eLife.44478.","journal-title":"Elife"},{"key":"2447_CR141","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1124\/pr.56.4.3","volume":"56","author":"A Hoeben","year":"2004","unstructured":"Hoeben A, Landuyt B, Highley MS, Wildiers H, Van Oosterom AT, De Bruijn EA. Vascular endothelial growth factor and angiogenesis. Pharmacol Rev. 2004;56:549\u201380. https:\/\/doi.org\/10.1124\/pr.56.4.3.","journal-title":"Pharmacol Rev"},{"key":"2447_CR142","first-page":"455","volume":"59","author":"CS Melincovici","year":"2018","unstructured":"Melincovici CS, Bo\u015fca AB, \u015eu\u015fman S, M\u0103rginean M, Mihu C, Istrate M, et al. Vascular endothelial growth factor (VEGF) - key factor in normal and pathological angiogenesis. Rom J Morphol Embryol. 2018;59:455\u201367.","journal-title":"Rom J Morphol Embryol"},{"key":"2447_CR143","first-page":"1029","volume":"146","author":"HF Dvorak","year":"1995","unstructured":"Dvorak HF, Brown LF, Detmar M, Dvorak AM. Vascular permeability factor\/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol. 1995;146:1029\u201339.","journal-title":"Am J Pathol"},{"key":"2447_CR144","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1152\/jappl.1996.81.1.355","volume":"81","author":"EC Breen","year":"1996","unstructured":"Breen EC, Johnson EC, Wagner H, Tseng HM, Sung LA, Wagner PD. Angiogenic growth factor mRNA responses in muscle to a single bout of exercise. J Appl Physiol. 1996;81:355\u201361. https:\/\/doi.org\/10.1152\/jappl.1996.81.1.355.","journal-title":"J Appl Physiol"},{"key":"2447_CR145","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.73592","volume":"13","author":"M Verma","year":"2024","unstructured":"Verma M, Asakura Y, Wang X, Zhou K, \u00dcnverdi M, Kann AP, et al. Endothelial cell signature in muscle stem cells validated by VEGFA-FLT1-AKT1 axis promoting survival of muscle stem cell. Elife. 2024;13:e73592. https:\/\/doi.org\/10.7554\/eLife.73592.","journal-title":"Elife"},{"key":"2447_CR146","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/s0022-2828(03)00006-3","volume":"35","author":"V Chintalgattu","year":"2003","unstructured":"Chintalgattu V, Nair DM, Katwa LC. Cardiac myofibroblasts: a novel source of vascular endothelial growth factor (VEGF) and its receptors Flt-1 and KDR. J Mol Cell Cardiol. 2003;35:277\u201386. https:\/\/doi.org\/10.1016\/s0022-2828(03)00006-3.","journal-title":"J Mol Cell Cardiol"},{"key":"2447_CR147","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1158\/0008-5472.CAN-08-1879","volume":"69","author":"F Spinella","year":"2009","unstructured":"Spinella F, Garrafa E, Di Castro V, Rosan\u00f2 L, Nicotra MR, Caruso A, et al. Endothelin-1 stimulates lymphatic endothelial cells and lymphatic vessels to grow and invade. Cancer Res. 2009;69:2669\u201376. https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-1879.","journal-title":"Cancer Res"},{"key":"2447_CR148","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19041264","volume":"19","author":"CJ Peach","year":"2018","unstructured":"Peach CJ, Mignone VW, Arruda MA, Alcobia DC, Hill SJ, Kilpatrick LE, et al. Molecular pharmacology of VEGF-A isoforms: binding and signalling at VEGFR2. Int J Mol Sci. 2018;19:1264. https:\/\/doi.org\/10.3390\/ijms19041264.","journal-title":"Int J Mol Sci"},{"key":"2447_CR149","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1242\/dev.126.6.1149","volume":"126","author":"HP Gerber","year":"1999","unstructured":"Gerber HP, Hillan KJ, Ryan AM, Kowalski J, Keller GA, Rangell L, et al. VEGF is required for growth and survival in neonatal mice. Development. 1999;126:1149\u201359. https:\/\/doi.org\/10.1242\/dev.126.6.1149.","journal-title":"Development"},{"key":"2447_CR150","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1002\/aja.1002030109","volume":"203","author":"DJ Dumont","year":"1995","unstructured":"Dumont DJ, Fong GH, Puri MC, Gradwohl G, Alitalo K, Breitman ML. Vascularization of the mouse embryo: a study of flk-1, tek, tie, and vascular endothelial growth factor expression during development. Dev Dyn. 1995;203:80\u201392. https:\/\/doi.org\/10.1002\/aja.1002030109.","journal-title":"Dev Dyn"},{"key":"2447_CR151","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1146\/annurev.cb.11.110195.000445","volume":"11","author":"W Risau","year":"1995","unstructured":"Risau W, Flamme I. Vasculogenesis. Annu Rev Cell Dev Biol. 1995;11:73\u201391. https:\/\/doi.org\/10.1146\/annurev.cb.11.110195.000445.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"2447_CR152","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1097\/01.ccm.0000159563.97092.a7","volume":"33","author":"A Janvier","year":"2005","unstructured":"Janvier A, Nadeau S, Baribeau J, Perreault T. Role of vascular endothelial growth factor receptor 1 and vascular endothelial growth factor receptor 2 in the vasodilator response to vascular endothelial growth factor in the neonatal piglet lung. Crit Care Med. 2005;33:860\u20136. https:\/\/doi.org\/10.1097\/01.ccm.0000159563.97092.a7.","journal-title":"Crit Care Med"},{"key":"2447_CR153","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/35025220","volume":"407","author":"P Carmeliet","year":"2000","unstructured":"Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature. 2000;407:249\u201357. https:\/\/doi.org\/10.1038\/35025220.","journal-title":"Nature"},{"issue":"Suppl 3","key":"2447_CR154","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1159\/000088478","volume":"69","author":"P Carmeliet","year":"2005","unstructured":"Carmeliet P. VEGF as a key mediator of angiogenesis in cancer. Oncology. 2005;69(Suppl 3):4\u201310. https:\/\/doi.org\/10.1159\/000088478.","journal-title":"Oncology"},{"key":"2447_CR155","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/s0002-9394(14)75794-0","volume":"118","author":"AP Adamis","year":"1994","unstructured":"Adamis AP, Miller JW, Bernal MT, D\u2019Amico DJ, Folkman J, Yeo TK, et al. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol. 1994;118:445\u201350. https:\/\/doi.org\/10.1016\/s0002-9394(14)75794-0.","journal-title":"Am J Ophthalmol"},{"key":"2447_CR156","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1056\/NEJM199412013312203","volume":"331","author":"LP Aiello","year":"1994","unstructured":"Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med. 1994;331:1480\u20137. https:\/\/doi.org\/10.1056\/NEJM199412013312203.","journal-title":"N Engl J Med"},{"key":"2447_CR157","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH649>3.0.CO;2-E","volume":"191","author":"M Ikeda","year":"2000","unstructured":"Ikeda M, Hosoda Y, Hirose S, Okada Y, Ikeda E. Expression of vascular endothelial growth factor isoforms and their receptors Flt-1, KDR, and neuropilin-1 in synovial tissues of rheumatoid arthritis. J Pathol. 2000;191:426\u201333. https:\/\/doi.org\/10.1002\/1096-9896(2000)9999:9999%3c::AID-PATH649%3e3.0.CO;2-E.","journal-title":"J Pathol"},{"key":"2447_CR158","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/s0002-9440(10)63808-4","volume":"162","author":"H Enomoto","year":"2003","unstructured":"Enomoto H, Inoki I, Komiya K, Shiomi T, Ikeda E, Obata K, et al. Vascular endothelial growth factor isoforms and their receptors are expressed in human osteoarthritic cartilage. Am J Pathol. 2003;162:171\u201381. https:\/\/doi.org\/10.1016\/s0002-9440(10)63808-4.","journal-title":"Am J Pathol"},{"key":"2447_CR159","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1161\/01.atv.18.7.1188","volume":"18","author":"MA Ramos","year":"1998","unstructured":"Ramos MA, Kuzuya M, Esaki T, Miura S, Satake S, Asai T, et al. Induction of macrophage VEGF in response to oxidized LDL and VEGF accumulation in human atherosclerotic lesions. Arterioscler Thromb Vasc Biol. 1998;18:1188\u201396. https:\/\/doi.org\/10.1161\/01.atv.18.7.1188.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2447_CR160","first-page":"610","volume":"24","author":"P-Y Yang","year":"2003","unstructured":"Yang P-Y, Rui Y-C, Jin Y-X, Li T-J, Qiu Y, Zhang L, et al. Antisense oligodeoxynucleotide inhibits vascular endothelial growth factor expression in U937 foam cells. Acta Pharmacol Sin. 2003;24:610\u20134.","journal-title":"Acta Pharmacol Sin"},{"key":"2447_CR161","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005139.pub4","volume":"2019","author":"SD Solomon","year":"2019","unstructured":"Solomon SD, Lindsley K, Vedula SS, Krzystolik MG, Hawkins BS. Anti\u2010vascular endothelial growth factor for neovascular age\u2010related macular degeneration. Cochrane Database Syst Rev. 2019;2019:CD005139. https:\/\/doi.org\/10.1002\/14651858.CD005139.pub4.","journal-title":"Cochrane Database Syst Rev"},{"key":"2447_CR162","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1056\/NEJM197111182852108","volume":"285","author":"J Folkman","year":"1971","unstructured":"Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med. 1971;285:1182\u20136. https:\/\/doi.org\/10.1056\/NEJM197111182852108.","journal-title":"N Engl J Med"},{"key":"2447_CR163","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/S0092-8674(00)80108-7","volume":"86","author":"D Hanahan","year":"1996","unstructured":"Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell. 1996;86:353\u201364. https:\/\/doi.org\/10.1016\/S0092-8674(00)80108-7.","journal-title":"Cell"},{"key":"2447_CR164","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/35036374","volume":"2","author":"G Bergers","year":"2000","unstructured":"Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, Tamaki K, et al. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol. 2000;2:737\u201344. https:\/\/doi.org\/10.1038\/35036374.","journal-title":"Nat Cell Biol"},{"key":"2447_CR165","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/sj.bjc.6604929","volume":"100","author":"JA Nagy","year":"2009","unstructured":"Nagy JA, Chang S-H, Dvorak AM, Dvorak HF. Why are tumour blood vessels abnormal and why is it important to know? Br J Cancer. 2009;100:865\u20139. https:\/\/doi.org\/10.1038\/sj.bjc.6604929.","journal-title":"Br J Cancer"},{"key":"2447_CR166","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1007\/s00421-022-05128-6","volume":"123","author":"M Ross","year":"2023","unstructured":"Ross M, Kargl CK, Ferguson R, Gavin TP, Hellsten Y. Exercise-induced skeletal muscle angiogenesis: impact of age, sex, angiocrines and cellular mediators. Eur J Appl Physiol. 2023;123:1415\u201332. https:\/\/doi.org\/10.1007\/s00421-022-05128-6.","journal-title":"Eur J Appl Physiol"},{"key":"2447_CR167","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s40279-024-02120-2","volume":"55","author":"KS M\u00f8lmen","year":"2025","unstructured":"M\u00f8lmen KS, Almquist NW, Skattebo \u00d8. Effects of exercise training on mitochondrial and capillary growth in human skeletal muscle: a systematic review and meta-regression. Sports Med. 2025;55:115\u201344. https:\/\/doi.org\/10.1007\/s40279-024-02120-2.","journal-title":"Sports Med"},{"key":"2447_CR168","doi-asserted-by":"publisher","first-page":"H759","DOI":"10.1152\/ajpheart.00786.2004","volume":"288","author":"PG Lloyd","year":"2005","unstructured":"Lloyd PG, Prior BM, Li H, Yang HT, Terjung RL. VEGF receptor antagonism blocks arteriogenesis, but only partially inhibits angiogenesis, in skeletal muscle of exercise-trained rats. Am J Physiol Heart Circ Physiol. 2005;288:H759\u201368. https:\/\/doi.org\/10.1152\/ajpheart.00786.2004.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2447_CR169","doi-asserted-by":"publisher","first-page":"H679","DOI":"10.1152\/ajpheart.1999.276.2.H679","volume":"276","author":"T Gustafsson","year":"1999","unstructured":"Gustafsson T, Puntschart A, Kaijser L, Jansson E, Sundberg CJ. Exercise-induced expression of angiogenesis-related transcription and growth factors in human skeletal muscle. Am J Physiol Heart Circ Physiol. 1999;276:H679\u201385. https:\/\/doi.org\/10.1152\/ajpheart.1999.276.2.H679.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2447_CR170","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1152\/japplphysiol.01103.2006","volume":"103","author":"T Gustafsson","year":"2007","unstructured":"Gustafsson T, Rundqvist H, Norrbom J, Rullman E, Jansson E, Sundberg CJ. The influence of physical training on the angiopoietin and VEGF-A systems in human skeletal muscle. J Appl Physiol. 2007;103:1012\u201320. https:\/\/doi.org\/10.1152\/japplphysiol.01103.2006.","journal-title":"J Appl Physiol"},{"key":"2447_CR171","doi-asserted-by":"publisher","first-page":"H1668","DOI":"10.1152\/ajpheart.00743.2002","volume":"284","author":"PG Lloyd","year":"2003","unstructured":"Lloyd PG, Prior BM, Yang HT, Terjung RL. Angiogenic growth factor expression in rat skeletal muscle in response to exercise training. Am J Physiol Heart Circ Physiol. 2003;284:H1668\u201378. https:\/\/doi.org\/10.1152\/ajpheart.00743.2002.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2447_CR172","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1159\/000521584","volume":"59","author":"R Eguchi","year":"2022","unstructured":"Eguchi R, Kawabe J, Wakabayashi I. VEGF-independent angiogenic factors: beyond VEGF\/VEGFR2 signaling. J Vasc Res. 2022;59:78\u201389. https:\/\/doi.org\/10.1159\/000521584.","journal-title":"J Vasc Res"},{"key":"2447_CR173","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1159\/000226127","volume":"46","author":"O Hudlicka","year":"2009","unstructured":"Hudlicka O, Brown MD. Adaptation of skeletal muscle microvasculature to increased or decreased blood flow: role of shear stress, nitric oxide and vascular endothelial growth factor. J Vasc Res. 2009;46:504\u201312. https:\/\/doi.org\/10.1159\/000226127.","journal-title":"J Vasc Res"},{"key":"2447_CR174","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1042\/BST20140197","volume":"42","author":"Y Hellsten","year":"2014","unstructured":"Hellsten Y, Hoier B. Capillary growth in human skeletal muscle: physiological factors and the balance between pro-angiogenic and angiostatic factors. Biochem Soc Trans. 2014;42:1616\u201322. https:\/\/doi.org\/10.1042\/BST20140197.","journal-title":"Biochem Soc Trans"},{"key":"2447_CR175","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/nature03952","volume":"437","author":"E Tzima","year":"2005","unstructured":"Tzima E, Irani-Tehrani M, Kiosses WB, Dejana E, Schultz DA, Engelhardt B, et al. A mechanosensory complex that mediates the endothelial cell response to fluid shear stress. Nature. 2005;437:426\u201331. https:\/\/doi.org\/10.1038\/nature03952.","journal-title":"Nature"},{"key":"2447_CR176","doi-asserted-by":"publisher","DOI":"10.15252\/embj.201899322","author":"S Urner","year":"2019","unstructured":"Urner S, Planas\u2010Paz L, Hilger LS, Henning C, Branopolski A, Kelly\u2010Goss M, et al. Identification of ILK as a critical regulator of VEGFR3 signalling and lymphatic vascular growth. EMBO J. 2019. https:\/\/doi.org\/10.15252\/embj.201899322.","journal-title":"EMBO J"},{"key":"2447_CR177","doi-asserted-by":"publisher","first-page":"H336","DOI":"10.1152\/ajpheart.01105.2004","volume":"289","author":"M Milkiewicz","year":"2005","unstructured":"Milkiewicz M, Hudlicka O, Brown MD, Silgram H. Nitric oxide, VEGF, and VEGFR-2: interactions in activity-induced angiogenesis in rat skeletal muscle. Am J Physiol Heart Circ Physiol. 2005;289:H336\u201343. https:\/\/doi.org\/10.1152\/ajpheart.01105.2004.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2447_CR178","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1096\/fj.04-2304fje","volume":"19","author":"H Ameln","year":"2005","unstructured":"Ameln H, Gustafsson T, Sundberg CJ, Okamoto K, Jansson E, Poellinger L, et al. Physiological activation of hypoxia inducible factor-1 in human skeletal muscle. FASEB J. 2005;19:1009\u201311. https:\/\/doi.org\/10.1096\/fj.04-2304fje.","journal-title":"FASEB J"},{"key":"2447_CR179","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1038\/nature06613","volume":"451","author":"Z Arany","year":"2008","unstructured":"Arany Z, Foo S-Y, Ma Y, Ruas JL, Bommi-Reddy A, Girnun G, et al. HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1\u03b1. Nature. 2008;451:1008\u201312. https:\/\/doi.org\/10.1038\/nature06613.","journal-title":"Nature"},{"key":"2447_CR180","doi-asserted-by":"publisher","first-page":"C272","DOI":"10.1152\/ajpcell.00297.2025","volume":"329","author":"J Arag\u00f3n-Vela","year":"2025","unstructured":"Arag\u00f3n-Vela J, Casuso RA. Effect of hypoxia-inducible factor 1 on vascular endothelial growth factor expression in exercised human skeletal muscle: a systematic review and meta-analysis. Am J Physiol Cell Physiol. 2025;329:C272\u201382. https:\/\/doi.org\/10.1152\/ajpcell.00297.2025.","journal-title":"Am J Physiol Cell Physiol"},{"key":"2447_CR181","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1097\/JES.0b013e31819c2e9b","volume":"37","author":"TP Gavin","year":"2009","unstructured":"Gavin TP. Basal and exercise-induced regulation of skeletal muscle capillarization. Exerc Sport Sci Rev. 2009;37:86. https:\/\/doi.org\/10.1097\/JES.0b013e31819c2e9b.","journal-title":"Exerc Sport Sci Rev"},{"key":"2447_CR182","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1113\/EP085318","volume":"101","author":"ME Lindholm","year":"2016","unstructured":"Lindholm ME, Rundqvist H. Skeletal muscle hypoxia-inducible factor-1 and exercise. Exp Physiol. 2016;101:28\u201332. https:\/\/doi.org\/10.1113\/EP085318.","journal-title":"Exp Physiol"},{"key":"2447_CR183","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2019.00238","author":"M Bellafiore","year":"2019","unstructured":"Bellafiore M, Battaglia G, Bianco A, Palma A. Expression pattern of angiogenic factors in healthy heart in response to physical exercise intensity. Front Physiol. 2019. https:\/\/doi.org\/10.3389\/fphys.2019.00238.","journal-title":"Front Physiol"},{"key":"2447_CR184","doi-asserted-by":"publisher","first-page":"H857","DOI":"10.1152\/ajpheart.00082.2010","volume":"299","author":"B H\u00f8ier","year":"2010","unstructured":"H\u00f8ier B, Olsen K, Nyberg M, Bangsbo J, Hellsten Y. Contraction-induced secretion of VEGF from skeletal muscle cells is mediated by adenosine. Am J Physiol Heart Circ Physiol. 2010;299:H857\u201362. https:\/\/doi.org\/10.1152\/ajpheart.00082.2010.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2447_CR185","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15557","volume":"8","author":"C Morland","year":"2017","unstructured":"Morland C, Andersson KA, Haugen \u00d8P, Hadzic A, Kleppa L, Gille A, et al. Exercise induces cerebral VEGF and angiogenesis via the lactate receptor HCAR1. Nat Commun. 2017;8:15557. https:\/\/doi.org\/10.1038\/ncomms15557.","journal-title":"Nat Commun"},{"key":"2447_CR186","doi-asserted-by":"publisher","first-page":"R283","DOI":"10.1152\/ajpregu.00840.2004","volume":"289","author":"TH Adair","year":"2005","unstructured":"Adair TH. Growth regulation of the vascular system: an emerging role for adenosine. Am J Physiol Regul Integr Comp Physiol. 2005;289:R283\u201396. https:\/\/doi.org\/10.1152\/ajpregu.00840.2004.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"2447_CR187","doi-asserted-by":"publisher","first-page":"R975","DOI":"10.1152\/ajpregu.00677.2007","volume":"294","author":"Y Hellsten","year":"2008","unstructured":"Hellsten Y, Rufener N, Nielsen JJ, H\u00f8ier B, Krustrup P, Bangsbo J. Passive leg movement enhances interstitial VEGF protein, endothelial cell proliferation, and eNOS mRNA content in human skeletal muscle. Am J Physiol Regul Integr Comp Physiol. 2008;294:R975\u201382. https:\/\/doi.org\/10.1152\/ajpregu.00677.2007.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"2447_CR188","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1113\/jphysiol.2002.037051","volume":"550","author":"L H\u00f6ffner","year":"2003","unstructured":"H\u00f6ffner L, Nielsen JJ, Langberg H, Hellsten Y. Exercise but not prostanoids enhance levels of vascular endothelial growth factor and other proliferative agents in human skeletal muscle interstitium. J Physiol. 2003;550:217\u201325. https:\/\/doi.org\/10.1113\/jphysiol.2002.037051.","journal-title":"J Physiol"},{"key":"2447_CR189","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1097\/HJH.0b013e3283379120","volume":"28","author":"AH Hansen","year":"2010","unstructured":"Hansen AH, Nielsen JJ, Saltin B, Hellsten Y. Exercise training normalizes skeletal muscle vascular endothelial growth factor levels in patients with essential hypertension. J Hypertens. 2010;28:1176. https:\/\/doi.org\/10.1097\/HJH.0b013e3283379120.","journal-title":"J Hypertens"},{"key":"2447_CR190","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1152\/japplphysiol.01031.2003","volume":"96","author":"RM Kraus","year":"2004","unstructured":"Kraus RM, Stallings HW, Yeager RC, Gavin TP. Circulating plasma VEGF response to exercise in sedentary and endurance-trained men. J Appl Physiol. 2004;96:1445\u201350. https:\/\/doi.org\/10.1152\/japplphysiol.01031.2003.","journal-title":"J Appl Physiol"},{"issue":"1","key":"2447_CR191","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1152\/japplphysiol.00993.2010","volume":"110","author":"Z Yan","year":"2011","unstructured":"Yan Z, Okutsu M, Akhtar YN, Lira VA. Regulation of exercise-induced fiber type transformation, mitochondrial biogenesis, and angiogenesis in skeletal muscle. J Appl Physiol. 2011;110(1):264\u201374. https:\/\/doi.org\/10.1152\/japplphysiol.00993.2010.","journal-title":"J Appl Physiol"},{"key":"2447_CR192","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1152\/japplphysiol.00710.2001","volume":"95","author":"M Huonker","year":"2003","unstructured":"Huonker M, Schmid A, Schmidt-Trucks\u00e4\u00df A, Grathwohl D, Keul J. Size and blood flow of central and peripheral arteries in highly trained able-bodied and disabled athletes. J Appl Physiol. 2003;95:685\u201391. https:\/\/doi.org\/10.1152\/japplphysiol.00710.2001.","journal-title":"J Appl Physiol"},{"key":"2447_CR193","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1007\/s00424-008-0563-9","volume":"457","author":"S Egginton","year":"2009","unstructured":"Egginton S. Invited review: activity-induced angiogenesis. Pflugers Arch Eur J Physiol. 2009;457:963\u201377. https:\/\/doi.org\/10.1007\/s00424-008-0563-9.","journal-title":"Pflugers Arch Eur J Physiol"},{"key":"2447_CR194","doi-asserted-by":"publisher","first-page":"229","DOI":"10.2174\/187221512802717321","volume":"6","author":"M Kambouris","year":"2012","unstructured":"Kambouris M, Ntalouka F, Ziogas G, Maffulli N. Predictive genomics DNA profiling for athletic performance. Recent Pat DNA Gene Seq. 2012;6:229\u201339. https:\/\/doi.org\/10.2174\/187221512802717321.","journal-title":"Recent Pat DNA Gene Seq"},{"key":"2447_CR195","doi-asserted-by":"publisher","first-page":"H1848","DOI":"10.1152\/ajpheart.01033.2005","volume":"290","author":"SJ Prior","year":"2006","unstructured":"Prior SJ, Hagberg JM, Paton CM, Douglass LW, Brown MD, McLenithan JC, et al. DNA sequence variation in the promoter region of the VEGF gene impacts VEGF gene expression and maximal oxygen consumption. Am J Physiol-Heart Circ Physiol. 2006;290:H1848\u201355. https:\/\/doi.org\/10.1152\/ajpheart.01033.2005.","journal-title":"Am J Physiol-Heart Circ Physiol."},{"key":"2447_CR196","doi-asserted-by":"publisher","first-page":"3281","DOI":"10.1161\/01.CIR.94.12.3281","volume":"94","author":"Y Tsurumi","year":"1996","unstructured":"Tsurumi Y, Takeshita S, Chen D, Kearney M, Rossow ST, Passeri J, et al. Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion. Circulation. 1996;94:3281\u201390. https:\/\/doi.org\/10.1161\/01.CIR.94.12.3281.","journal-title":"Circulation"},{"key":"2447_CR197","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1161\/01.CIR.97.12.1114","volume":"97","author":"I Baumgartner","year":"1998","unstructured":"Baumgartner I, Pieczek A, Manor O, Blair R, Kearney M, Walsh K, et al. Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation. 1998;97:1114\u201323. https:\/\/doi.org\/10.1161\/01.CIR.97.12.1114.","journal-title":"Circulation"},{"key":"2447_CR198","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1161\/01.CIR.92.9.365","volume":"92","author":"T Asahara","year":"1995","unstructured":"Asahara T, Bauters C, Zheng LP, Takeshita S, Bunting S, Ferrara N, et al. Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. Circulation. 1995;92:365\u201371. https:\/\/doi.org\/10.1161\/01.CIR.92.9.365.","journal-title":"Circulation"},{"key":"2447_CR199","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/S1043-0679(03)70003-3","volume":"15","author":"JL Yeh","year":"2003","unstructured":"Yeh JL, Giordano FJ. Gene-based therapeutic angiogenesis. Semin Thorac Cardiovasc Surg. 2003;15:236\u201349. https:\/\/doi.org\/10.1016\/S1043-0679(03)70003-3.","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"2447_CR200","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1093\/eurheartj\/ehw547","volume":"38","author":"S Yl\u00e4-Herttuala","year":"2017","unstructured":"Yl\u00e4-Herttuala S, Bridges C, Katz MG, Korpisalo P. Angiogenic gene therapy in cardiovascular diseases: dream or vision? Eur Heart J. 2017;38:1365\u201371. https:\/\/doi.org\/10.1093\/eurheartj\/ehw547.","journal-title":"Eur Heart J"},{"key":"2447_CR201","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s40291-022-00632-z","volume":"27","author":"FJ Romeo","year":"2023","unstructured":"Romeo FJ, Mavropoulos SA, Ishikawa K. Progress in clinical gene therapy for cardiac disorders. Mol Diagn Ther. 2023;27:179\u201391. https:\/\/doi.org\/10.1007\/s40291-022-00632-z.","journal-title":"Mol Diagn Ther"},{"key":"2447_CR202","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2024-002817","volume":"11","author":"AJ Leikas","year":"2024","unstructured":"Leikas AJ, Hartikainen JEK, Kastrup J, Mathur A, Gy\u00f6ngy\u00f6si M, Fern\u00e1ndez-Avil\u00e9s F, et al. Clinical development and proof of principle testing of new regenerative vascular endothelial growth factor-d therapy for refractory angina: rationale and design of the phase 2 ReGenHeart trial. Open Heart. 2024;11:e002817. https:\/\/doi.org\/10.1136\/openhrt-2024-002817.","journal-title":"Open Heart"},{"key":"2447_CR203","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1093\/eurheartj\/ehx352","volume":"38","author":"J Hartikainen","year":"2017","unstructured":"Hartikainen J, Hassinen I, Hedman A, Kivel\u00e4 A, Saraste A, Knuuti J, et al. Adenoviral intramyocardial VEGF-D\u0394N\u0394C gene transfer increases myocardial perfusion reserve in refractory angina patients: a phase I\/IIa study with 1-year follow-up. Eur Heart J. 2017;38:2547\u201355. https:\/\/doi.org\/10.1093\/eurheartj\/ehx352.","journal-title":"Eur Heart J"},{"key":"2447_CR204","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/s41434-021-00295-1","volume":"29","author":"AJ Leikas","year":"2022","unstructured":"Leikas AJ, Hassinen I, Hedman A, Kivel\u00e4 A, Yl\u00e4-Herttuala S, Hartikainen JEK. Long-term safety and efficacy of intramyocardial adenovirus-mediated VEGF-D\u0394N\u0394C gene therapy eight-year follow-up of phase I KAT301 study. Gene Ther. 2022;29:289\u201393. https:\/\/doi.org\/10.1038\/s41434-021-00295-1.","journal-title":"Gene Ther"},{"key":"2447_CR205","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242115835","volume":"24","author":"N Naumann","year":"2023","unstructured":"Naumann N, Pa\u00dfreiter A, Thomas A, Krug O, Walpurgis K, Thevis M. Analysis of potential gene doping preparations for transgenic DNA in the context of sports drug testing programs. Int J Mol Sci. 2023;24:15835. https:\/\/doi.org\/10.3390\/ijms242115835.","journal-title":"Int J Mol Sci"},{"key":"2447_CR206","unstructured":"hEPO mRNA Product Website. HEPO - Etherna Shop. 2025. https:\/\/shop.etherna.be\/products\/hepo. Accessed 18 Aug 2025"},{"key":"2447_CR207","unstructured":"EPO mRNA - Gene Replacement mRNA Product Website. OZ Biosci. 2025. https:\/\/ozbiosciences.com\/gene-replacement-mrna\/128-epo-mrna.html. Accessed 18 Aug 2025"},{"key":"2447_CR208","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","volume":"6","author":"X Hou","year":"2021","unstructured":"Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6:1078\u201394. https:\/\/doi.org\/10.1038\/s41578-021-00358-0.","journal-title":"Nat Rev Mater"},{"key":"2447_CR209","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aba1028","volume":"7","author":"RS Riley","year":"2021","unstructured":"Riley RS, Kashyap MV, Billingsley MM, White B, Alameh M-G, Bose SK, et al. Ionizable lipid nanoparticles for in utero mRNA delivery. Sci Adv. 2021;7:eaba1028. https:\/\/doi.org\/10.1126\/sciadv.aba1028.","journal-title":"Sci Adv"},{"key":"2447_CR210","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/apha.12857","volume":"221","author":"SP Mortensen","year":"2017","unstructured":"Mortensen SP, Egginton S, Madsen M, Hansen JB, Munch GDW, Iepsen UW, et al. Alpha adrenergic receptor blockade increases capillarization and fractional O2 extraction and lowers blood flow in contracting human skeletal muscle. Acta Physiol. 2017;221:32\u201343. https:\/\/doi.org\/10.1111\/apha.12857.","journal-title":"Acta Physiol"},{"key":"2447_CR211","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1177\/1753944718786926","volume":"12","author":"R Deev","year":"2018","unstructured":"Deev R, Plaksa I, Bozo I, Mzhavanadze N, Suchkov I, Chervyakov Y, et al. Results of 5-year follow-up study in patients with peripheral artery disease treated with PL-VEGF165 for intermittent claudication. Ther Adv Cardiovasc Dis. 2018;12:237\u201346. https:\/\/doi.org\/10.1177\/1753944718786926.","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"2447_CR212","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1161\/CIRCULATIONAHA.108.784371","volume":"118","author":"J Tongers","year":"2008","unstructured":"Tongers J, Roncalli JG, Losordo DW. Therapeutic angiogenesis for critical limb ischemia. Circulation. 2008;118:9\u201316. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.108.784371.","journal-title":"Circulation"},{"key":"2447_CR213","unstructured":"Genentech, Inc. A Phase II, Double-Blind, Randomized, Placebo-Controlled Study to Assess the Effect of Topical Recombinant Human Vascular Endothelial Growth Factor (Telbermin) for Induction of Healing of Diabetic Foot Ulcers. clinicaltrials.gov; 2013 Jan. Report No.: NCT00351767. https:\/\/clinicaltrials.gov\/study\/NCT00351767. Accessed 10 Feb 2026"},{"key":"2447_CR214","doi-asserted-by":"publisher","first-page":"30","DOI":"10.12968\/jowc.2008.17.1.27917","volume":"17","author":"JR Hanft","year":"2008","unstructured":"Hanft JR, Pollak RA, Barbul A, van Gils C, Kwon PS, Gray SM, et al. Phase I trial on the safety of topical rhVEGF on chronic neuropathic diabetic foot ulcers. J Wound Care. 2008;17:30\u20137. https:\/\/doi.org\/10.12968\/jowc.2008.17.1.27917.","journal-title":"J Wound Care"},{"key":"2447_CR215","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1161\/01.CIR.0000061911.47710.8A","volume":"107","author":"TD Henry","year":"2003","unstructured":"Henry TD, Annex BH, McKendall GR, Azrin MA, Lopez JJ, Giordano FJ, et al. The VIVA Trial. Circulation. 2003;107:1359\u201365. https:\/\/doi.org\/10.1161\/01.CIR.0000061911.47710.8A.","journal-title":"Circulation"},{"key":"2447_CR216","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1038\/mt.2009.70","volume":"17","author":"DJ Stewart","year":"2009","unstructured":"Stewart DJ, Kutryk MJB, Fitchett D, Freeman M, Camack N, Su Y, et al. VEGF gene therapy fails to improve perfusion of ischemic myocardium in patients with advanced coronary disease: results of the NORTHERN trial. Mol Ther J Am Soc Gene Ther. 2009;17:1109\u201315. https:\/\/doi.org\/10.1038\/mt.2009.70.","journal-title":"Mol Ther J Am Soc Gene Ther"},{"key":"2447_CR217","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1038\/sj.gt.3302802","volume":"13","author":"DJ Stewart","year":"2006","unstructured":"Stewart DJ, Hilton JD, Arnold JMO, Gregoire J, Rivard A, Archer SL, et al. Angiogenic gene therapy in patients with nonrevascularizable ischemic heart disease: a phase 2 randomized, controlled trial of AdVEGF121 (AdVEGF121) versus maximum medical treatment. Gene Ther. 2006;13:1503\u201311. https:\/\/doi.org\/10.1038\/sj.gt.3302802.","journal-title":"Gene Ther"},{"key":"2447_CR218","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.124.014054","volume":"17","author":"K Nakamura","year":"2024","unstructured":"Nakamura K, Henry TD, Traverse JH, Latter DA, Mokadam NA, Answini GA, et al. Angiogenic gene therapy for refractory angina: results of the EXACT Phase 2 trial. Circ Cardiovasc Interv. 2024;17:e014054. https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.124.014054.","journal-title":"Circ Cardiovasc Interv"},{"key":"2447_CR219","unstructured":"XyloCor Therapeutics, Inc. Endocardial Delivery of XC001 Gene Therapy for Refractory Angina Coronary Treatment: A 26-Week (With 26 Week Extension) Phase 2b Randomized, Multi-Center, Double-Blind, Sham Controlled Study to Evaluate Efficacy and Safety. clinicaltrials.gov; 2025 July. Report No.: NCT07048808. https:\/\/clinicaltrials.gov\/study\/NCT07048808. Accessed 25 Feb 2026"},{"key":"2447_CR220","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1038\/s41598-024-51712-5","volume":"14","author":"J Lampela","year":"2024","unstructured":"Lampela J, Pajula J, J\u00e4rvel\u00e4inen N, Siimes S, Laham-Karam N, Kivel\u00e4 A, et al. Cardiac vein retroinjections provide an efficient approach for global left ventricular gene transfer with adenovirus and adeno-associated virus. Sci Rep. 2024;14:1467. https:\/\/doi.org\/10.1038\/s41598-024-51712-5.","journal-title":"Sci Rep"},{"key":"2447_CR221","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.jacc.2007.06.010","volume":"50","author":"TD Henry","year":"2007","unstructured":"Henry TD, Grines CL, Watkins MW, Dib N, Barbeau G, Moreadith R, et al. Effects of Ad5FGF-4 in patients with angina: an analysis of pooled data from the AGENT-3 and AGENT-4 trials. J Am Coll Cardiol. 2007;50:1038\u201346. https:\/\/doi.org\/10.1016\/j.jacc.2007.06.010.","journal-title":"J Am Coll Cardiol"},{"key":"2447_CR222","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1007\/s11033-008-9315-3","volume":"36","author":"Z-J Yang","year":"2009","unstructured":"Yang Z-J, Zhang Y-R, Chen B, Zhang S-L, Jia E-Z, Wang L-S, et al. Phase I clinical trial on intracoronary administration of Ad-hHGF treating severe coronary artery disease. Mol Biol Rep. 2009;36:1323\u20139. https:\/\/doi.org\/10.1007\/s11033-008-9315-3.","journal-title":"Mol Biol Rep"},{"key":"2447_CR223","doi-asserted-by":"publisher","first-page":"16982","DOI":"10.1021\/acsnano.1c04996","volume":"15","author":"R Tenchov","year":"2021","unstructured":"Tenchov R, Bird R, Curtze AE, Zhou Q. Lipid nanoparticles\u2500from liposomes to mRNA vaccine delivery, a landscape of research diversity and advancement. ACS Nano. 2021;15:16982\u20137015. https:\/\/doi.org\/10.1021\/acsnano.1c04996.","journal-title":"ACS Nano"},{"key":"2447_CR224","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1126\/science.1690918","volume":"247","author":"JA Wolff","year":"1990","unstructured":"Wolff JA, Malone RW, Williams P, Chong W, Acsadi G, Jani A, et al. Direct gene transfer into mouse muscle in vivo. Science. 1990;247:1465\u20138. https:\/\/doi.org\/10.1126\/science.1690918.","journal-title":"Science"},{"key":"2447_CR225","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/bjp.2008.144","volume":"154","author":"DJ Wells","year":"2008","unstructured":"Wells DJ. Gene doping: the hype and the reality. Br J Pharmacol. 2008;154:623\u201331. https:\/\/doi.org\/10.1038\/bjp.2008.144.","journal-title":"Br J Pharmacol"},{"key":"2447_CR226","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1056\/NEJMoa2309676","volume":"390","author":"H Frangoul","year":"2024","unstructured":"Frangoul H, Locatelli F, Sharma A, Bhatia M, Mapara M, Molinari L, et al. Exagamglogene autotemcel for severe sickle cell disease. N Engl J Med. 2024;390:1649\u201362. https:\/\/doi.org\/10.1056\/NEJMoa2309676.","journal-title":"N Engl J Med"},{"key":"2447_CR227","doi-asserted-by":"publisher","DOI":"10.3390\/cells13100800","volume":"13","author":"M Laurent","year":"2024","unstructured":"Laurent M, Geoffroy M, Pavani G, Guiraud S. CRISPR-based gene therapies: from preclinical to clinical treatments. Cells. 2024;13:800. https:\/\/doi.org\/10.3390\/cells13100800.","journal-title":"Cells"},{"key":"2447_CR228","unstructured":"Palmgren G. Overview CRISPR Clinical Trials 2025. CRISPR Med. News. 2025. https:\/\/crisprmedicinenews.com\/clinical-trials\/. Accessed 4 Jul 2025"},{"key":"2447_CR229","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01750-2","volume":"9","author":"Y Zheng","year":"2024","unstructured":"Zheng Y, Li Y, Zhou K, Li T, VanDusen NJ, Hua Y. Precise genome-editing in human diseases: mechanisms, strategies and applications. Signal Transduct Target Ther. 2024;9:47. https:\/\/doi.org\/10.1038\/s41392-024-01750-2.","journal-title":"Signal Transduct Target Ther"},{"key":"2447_CR230","doi-asserted-by":"publisher","DOI":"10.1126\/science.adv9789","author":"G Faure","year":"2025","unstructured":"Faure G, Saito M, Wilkinson ME, Quinones-Olvera N, Xu P, Flam-Shepherd D, et al. TIGR-Tas: a family of modular RNA-guided DNA-targeting systems in prokaryotes and their viruses. Science. 2025. https:\/\/doi.org\/10.1126\/science.adv9789.","journal-title":"Science"},{"key":"2447_CR231","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/s41434-022-00322-9","volume":"29","author":"H Korpela","year":"2022","unstructured":"Korpela H, Lampela J, Airaksinen J, J\u00e4rvel\u00e4inen N, Siimes S, Valli K, et al. AAV2-VEGF-B gene therapy failed to induce angiogenesis in ischemic porcine myocardium due to inflammatory responses. Gene Ther. 2022;29:643\u201352. https:\/\/doi.org\/10.1038\/s41434-022-00322-9.","journal-title":"Gene Ther"},{"key":"2447_CR232","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1089\/hum.2020.006","volume":"31","author":"C Rossi","year":"2020","unstructured":"Rossi C, Lees M, Mehta V, Heikura T, Martin J, Zachary I, et al. Comparison of efficiency and function of vascular endothelial growth factor adenovirus vectors in endothelial cells for gene therapy of placental insufficiency. Hum Gene Ther. 2020;31:1190\u2013202. https:\/\/doi.org\/10.1089\/hum.2020.006.","journal-title":"Hum Gene Ther"},{"key":"2447_CR233","doi-asserted-by":"publisher","first-page":"16037","DOI":"10.1074\/jbc.M109.001123","volume":"284","author":"PI Toivanen","year":"2009","unstructured":"Toivanen PI, Nieminen T, Viitanen L, Alitalo A, Roschier M, Jauhiainen S, et al. Novel vascular endothelial growth factor D variants with increased biological activity. J Biol Chem. 2009;284:16037\u201348. https:\/\/doi.org\/10.1074\/jbc.M109.001123.","journal-title":"J Biol Chem"},{"key":"2447_CR234","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/nature14483","volume":"522","author":"L Klotz","year":"2015","unstructured":"Klotz L, Norman S, Vieira JM, Masters M, Rohling M, Dub\u00e9 KN, et al. Cardiac lymphatics are heterogeneous in origin and respond to injury. Nature. 2015;522:62\u20137. https:\/\/doi.org\/10.1038\/nature14483.","journal-title":"Nature"},{"key":"2447_CR235","doi-asserted-by":"publisher","first-page":"4500","DOI":"10.1242\/dev.113639","volume":"141","author":"HI Chen","year":"2014","unstructured":"Chen HI, Sharma B, Akerberg BN, Numi HJ, Kivel\u00e4 R, Saharinen P, et al. The sinus venosus contributes to coronary vasculature through VEGFC-stimulated angiogenesis. Dev Camb Engl. 2014;141:4500\u201312. https:\/\/doi.org\/10.1242\/dev.113639.","journal-title":"Dev Camb Engl"},{"key":"2447_CR236","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-99416-8","volume":"15","author":"A Shinaoka","year":"2025","unstructured":"Shinaoka A, Kimata Y. Lymphatic flow dynamics under exercise load assessed with thoracic duct ultrasonography. Sci Rep. 2025;15:14323. https:\/\/doi.org\/10.1038\/s41598-025-99416-8.","journal-title":"Sci Rep"},{"key":"2447_CR237","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/j.1469-7793.1997.233bf.x","volume":"504","author":"E Havas","year":"1997","unstructured":"Havas E, Parviainen T, Vuorela J, Toivanen J, Nikula T, Vihko V. Lymph flow dynamics in exercising human skeletal muscle as detected by scintography. J Physiol. 1997;504:233\u20139. https:\/\/doi.org\/10.1111\/j.1469-7793.1997.233bf.x.","journal-title":"J Physiol"},{"key":"2447_CR238","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s00109-002-0397-4","volume":"81","author":"H-P Gerber","year":"2003","unstructured":"Gerber H-P, Ferrara N. The role of VEGF in normal and neoplastic hematopoiesis. J Mol Med. 2003;81:20\u201331. https:\/\/doi.org\/10.1007\/s00109-002-0397-4.","journal-title":"J Mol Med"},{"key":"2447_CR239","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1182\/blood-2003-07-2563","volume":"103","author":"C Cerdan","year":"2004","unstructured":"Cerdan C, Rouleau A, Bhatia M. VEGF-A165 augments erythropoietic development from human embryonic stem cells. Blood. 2004;103:2504\u201312. https:\/\/doi.org\/10.1182\/blood-2003-07-2563.","journal-title":"Blood"},{"key":"2447_CR240","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1084\/jem.20180752","volume":"216","author":"AC Greenwald","year":"2019","unstructured":"Greenwald AC, Licht T, Kumar S, Oladipupo SS, Iyer S, Grunewald M, et al. VEGF expands erythropoiesis via hypoxia-independent induction of erythropoietin in noncanonical perivascular stromal cells. J Exp Med. 2019;216:215\u201330. https:\/\/doi.org\/10.1084\/jem.20180752.","journal-title":"J Exp Med"},{"key":"2447_CR241","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1517\/13543784.13.7.829","volume":"13","author":"EJ Rebar","year":"2004","unstructured":"Rebar EJ. Development of pro-angiogenic engineered transcription factors for the treatment of cardiovascular disease. Expert Opin Investig Drugs. 2004;13:829\u201339. https:\/\/doi.org\/10.1517\/13543784.13.7.829.","journal-title":"Expert Opin Investig Drugs"},{"key":"2447_CR242","doi-asserted-by":"publisher","DOI":"10.1096\/fj.05-3720fje","author":"K Pajusola","year":"2005","unstructured":"Pajusola K, K\u00fcnnapuu J, Vuorikoski S, Soronen J, Andr\u00e9 H, Pereira T, et al. Stabilized HIF-1\u03b1 is superior to VEGF for angiogenesis in skeletal muscle via adeno-associated virus gene transfer. FASEB J. 2005. https:\/\/doi.org\/10.1096\/fj.05-3720fje.","journal-title":"FASEB J"},{"key":"2447_CR243","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.lfs.2011.01.006","volume":"88","author":"G Czibik","year":"2011","unstructured":"Czibik G, Gravning J, Martinov V, Ishaq B, Knudsen E, Attramadal H, et al. Gene therapy with hypoxia-inducible factor 1 alpha in skeletal muscle is cardioprotective in vivo. Life Sci. 2011;88:543\u201350. https:\/\/doi.org\/10.1016\/j.lfs.2011.01.006.","journal-title":"Life Sci"},{"key":"2447_CR244","doi-asserted-by":"publisher","first-page":"4587","DOI":"10.1093\/nar\/gkp425","volume":"37","author":"Y Benita","year":"2009","unstructured":"Benita Y, Kikuchi H, Smith AD, Zhang MQ, Chung DC, Xavier RJ. An integrative genomics approach identifies hypoxia inducible factor-1 (HIF-1)-target genes that form the core response to hypoxia. Nucleic Acids Res. 2009;37:4587\u2013602. https:\/\/doi.org\/10.1093\/nar\/gkp425.","journal-title":"Nucleic Acids Res"},{"key":"2447_CR245","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1101\/gad.914801","volume":"15","author":"DA Elson","year":"2001","unstructured":"Elson DA, Thurston G, Huang LE, Ginzinger DG, McDonald DM, Johnson RS, et al. Induction of hypervascularity without leakage or inflammation in transgenic mice overexpressing hypoxia-inducible factor-1alpha. Genes Dev. 2001;15:2520\u201332. https:\/\/doi.org\/10.1101\/gad.914801.","journal-title":"Genes Dev"},{"key":"2447_CR246","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.971795","volume":"13","author":"X Zhu","year":"2022","unstructured":"Zhu X, Jiang L, Wei X, Long M, Du Y. Roxadustat: not just for anemia. Front Pharmacol. 2022;13:971795. https:\/\/doi.org\/10.3389\/fphar.2022.971795.","journal-title":"Front Pharmacol"},{"key":"2447_CR247","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1111\/wrr.12708","volume":"27","author":"Y Zhu","year":"2019","unstructured":"Zhu Y, Wang Y, Jia Y, Xu J, Chai Y. Roxadustat promotes angiogenesis through HIF-1\u03b1\/VEGF\/VEGFR2 signaling and accelerates cutaneous wound healing in diabetic rats. Wound Repair Regen. 2019;27:324\u201334. https:\/\/doi.org\/10.1111\/wrr.12708.","journal-title":"Wound Repair Regen"},{"key":"2447_CR248","unstructured":"Wikipedia. Bertrand Moulinet. Wikipedia. 2025. https:\/\/en.wikipedia.org\/w\/index.php?title=Bertrand_Moulinet&oldid=1281486027. Accessed 5 Apr 2025"},{"key":"2447_CR249","doi-asserted-by":"publisher","DOI":"10.1002\/dta.3771","author":"A Checkouri","year":"2024","unstructured":"Checkouri A, Gheddar L, Arbouche N, Raul J-S, Kintz P. Simultaneous detection of three hypoxia-inducible factor stabilizers\u2014molidustat, roxadustat, and vadadustat\u2014in multiple keratinized matrices and its application in a doping context. Drug Test Anal. 2024. https:\/\/doi.org\/10.1002\/dta.3771.","journal-title":"Drug Test Anal"},{"key":"2447_CR250","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1021\/acs.analchem.3c03816","volume":"96","author":"LK Janssens","year":"2024","unstructured":"Janssens LK, De Wilde L, Van Eenoo P, Stove CP. Untargeted detection of HIF stabilizers in doping samples: activity-based screening with a stable in vitro bioassay. Anal Chem. 2024;96:238\u201347. https:\/\/doi.org\/10.1021\/acs.analchem.3c03816.","journal-title":"Anal Chem"},{"key":"2447_CR251","doi-asserted-by":"publisher","DOI":"10.1007\/s00604-025-07579-y","volume":"192","author":"RL Houston","year":"2025","unstructured":"Houston RL, Ayoko G, Izake EL. Light-driven biosensor for the rapid and selective detection of hypoxia-inducible factor-prolyl hydroxylase domain inhibitors in aqueous media and saliva. Mikrochim Acta. 2025;192:709. https:\/\/doi.org\/10.1007\/s00604-025-07579-y.","journal-title":"Mikrochim Acta"},{"key":"2447_CR252","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1515\/intox-2016-0011","volume":"9","author":"M Yazdani","year":"2016","unstructured":"Yazdani M. Technical aspects of oxygen level regulation in primary cell cultures: a review. Interdiscip Toxicol. 2016;9:85\u20139. https:\/\/doi.org\/10.1515\/intox-2016-0011.","journal-title":"Interdiscip Toxicol"},{"key":"2447_CR253","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1002\/dta.390","volume":"4","author":"S Beuck","year":"2012","unstructured":"Beuck S, Sch\u00e4nzer W, Thevis M. Hypoxia-inducible factor stabilizers and other small-molecule erythropoiesis-stimulating agents in current and preventive doping analysis. Drug Test Anal. 2012;4:830\u201345. https:\/\/doi.org\/10.1002\/dta.390.","journal-title":"Drug Test Anal"},{"key":"2447_CR254","doi-asserted-by":"publisher","first-page":"267","DOI":"10.5960\/dzsm.2014.143","volume":"65","author":"W Jelkmann","year":"2014","unstructured":"Jelkmann W. Xenon misuse in sports \u2013 increase of hypoxia-inducible factors and erythropoietin, or nothing but \u201ehot air\u201c? Dtsch Z Sportmed. 2014;65:267\u201371. https:\/\/doi.org\/10.5960\/dzsm.2014.143.","journal-title":"Dtsch Z Sportmed"},{"key":"2447_CR255","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1007\/s10517-025-06406-x","volume":"178","author":"PV Postnikov","year":"2025","unstructured":"Postnikov PV, Pronina IV, Polyansky DS, Efimova YA, Ordzhonikidze ZG, Badtieva VA, et al. Analysis of specific microRNAs expressed after intake of cobalt and xenon preparations for anti-doping control. Bull Exp Biol Med. 2025;178:726\u201332. https:\/\/doi.org\/10.1007\/s10517-025-06406-x.","journal-title":"Bull Exp Biol Med"},{"key":"2447_CR256","doi-asserted-by":"publisher","first-page":"2604","DOI":"10.1073\/pnas.041359198","volume":"98","author":"D Fukumura","year":"2001","unstructured":"Fukumura D, Gohongi T, Kadambi A, Izumi Y, Ang J, Yun C-O, et al. Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability. Proc Natl Acad Sci U S A. 2001;98:2604\u20139. https:\/\/doi.org\/10.1073\/pnas.041359198.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2447_CR257","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/j.1538-7836.2009.03424.x","volume":"7","author":"WC Sessa","year":"2009","unstructured":"Sessa WC. Molecular control of blood flow and angiogenesis: role of nitric oxide. J Thromb Haemost. 2009;7:35\u20137. https:\/\/doi.org\/10.1111\/j.1538-7836.2009.03424.x.","journal-title":"J Thromb Haemost"},{"key":"2447_CR258","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/nrd3228","volume":"9","author":"R Motterlini","year":"2010","unstructured":"Motterlini R, Otterbein LE. The therapeutic potential of carbon monoxide. Nat Rev Drug Discov. 2010;9:728\u201343. https:\/\/doi.org\/10.1038\/nrd3228.","journal-title":"Nat Rev Drug Discov"},{"key":"2447_CR259","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.1021\/acs.jmedchem.6b01153","volume":"61","author":"K Ling","year":"2018","unstructured":"Ling K, Men F, Wang W-C, Zhou Y-Q, Zhang H-W, Ye D-W. Carbon monoxide and its controlled release: therapeutic application, detection, and development of carbon monoxide releasing molecules (CORMs). J Med Chem. 2018;61:2611\u201335. https:\/\/doi.org\/10.1021\/acs.jmedchem.6b01153.","journal-title":"J Med Chem"},{"key":"2447_CR260","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.niox.2021.04.001","volume":"111\u2013112","author":"CP Hopper","year":"2021","unstructured":"Hopper CP, Zambrana PN, Goebel U, Wollborn J. A brief history of carbon monoxide and its therapeutic origins. Nitric Oxide. 2021;111\u2013112:45\u201363. https:\/\/doi.org\/10.1016\/j.niox.2021.04.001.","journal-title":"Nitric Oxide"},{"key":"2447_CR261","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1002\/med.21650","volume":"40","author":"X Yang","year":"2020","unstructured":"Yang X, de Caestecker M, Otterbein LE, Wang B. Carbon monoxide: an emerging therapy for acute kidney injury. Med Res Rev. 2020;40:1147\u201377. https:\/\/doi.org\/10.1002\/med.21650.","journal-title":"Med Res Rev"},{"key":"2447_CR262","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1089\/152308602753666280","volume":"4","author":"J Dulak","year":"2002","unstructured":"Dulak J, J\u00f3zkowicz A, Foresti R, Kasza A, Frick M, Huk I, et al. Heme oxygenase activity modulates vascular endothelial growth factor synthesis in vascular smooth muscle cells. Antioxid Redox Signal. 2002;4:229\u201340. https:\/\/doi.org\/10.1089\/152308602753666280.","journal-title":"Antioxid Redox Signal"},{"key":"2447_CR263","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1006\/mgme.1999.2851","volume":"67","author":"NA Daghman","year":"1999","unstructured":"Daghman NA, McHale CM, Savage GM, Price S, Winter PC, Maxwell AP, et al. Regulation of erythropoietin gene expression depends on two different oxygen-sensing mechanisms. Mol Genet Metab. 1999;67:113\u20137. https:\/\/doi.org\/10.1006\/mgme.1999.2851.","journal-title":"Mol Genet Metab"},{"key":"2447_CR264","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2024.1490205","author":"H Gatterer","year":"2024","unstructured":"Gatterer H, D\u00fcnnwald T, Woyke S, Faulhaber M, Schumacher YO, Schobersberger W. Low-dose carbon monoxide inhalation to increase total hemoglobin mass and endurance performance: scientific evidence and implications. Front Physiol. 2024. https:\/\/doi.org\/10.3389\/fphys.2024.1490205.","journal-title":"Front Physiol"},{"key":"2447_CR265","doi-asserted-by":"publisher","first-page":"9789","DOI":"10.1021\/acs.jmedchem.4c00823","volume":"67","author":"S Bansal","year":"2024","unstructured":"Bansal S, Liu D, Mao Q, Bauer N, Wang B. Carbon monoxide as a potential therapeutic agent: a molecular analysis of its safety profiles. J Med Chem. 2024;67:9789\u2013815. https:\/\/doi.org\/10.1021\/acs.jmedchem.4c00823.","journal-title":"J Med Chem"},{"key":"2447_CR266","unstructured":"Davis AC, Boburg S, Jr RO. Little-known makers of generic drugs played central role in opioid crisis, records show. Wash Post. 2019; https:\/\/www.washingtonpost.com\/investigations\/little-known-generic-drug-companies-played-central-role-in-opioid-crisis-documents-reveal\/2019\/07\/26\/95e08b46-ac5c-11e9-a0c9-6d2d7818f3da_story.html. Accessed 20 Apr 2025"},{"key":"2447_CR267","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1152\/japplphysiol.00185.2017","volume":"123","author":"C Siebenmann","year":"2017","unstructured":"Siebenmann C, Keiser S, Robach P, Lundby C. CORP: the assessment of total hemoglobin mass by carbon monoxide rebreathing. J Appl Physiol. 2017;123:645\u201354. https:\/\/doi.org\/10.1152\/japplphysiol.00185.2017.","journal-title":"J Appl Physiol"},{"key":"2447_CR268","doi-asserted-by":"publisher","first-page":"3865","DOI":"10.1242\/jeb.01225","volume":"207","author":"C Lundby","year":"2004","unstructured":"Lundby C, Pilegaard H, Andersen JL, van Hall G, Sander M, Calbet JAL. Acclimatization to 4100 m does not change capillary density or mRNA expression of potential angiogenesis regulatory factors in human skeletal muscle. J Exp Biol. 2004;207:3865\u201371. https:\/\/doi.org\/10.1242\/jeb.01225.","journal-title":"J Exp Biol"},{"key":"2447_CR269","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1136\/bmj.317.7165.1063","volume":"317","author":"AJ Peacock","year":"1998","unstructured":"Peacock AJ. Oxygen at high altitude. BMJ Brit Med J. 1998;317:1063\u20136. https:\/\/doi.org\/10.1136\/bmj.317.7165.1063.","journal-title":"BMJ\u00a0Brit Med J"},{"key":"2447_CR270","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00421-011-1955-7","volume":"112","author":"PD Wagner","year":"2012","unstructured":"Wagner PD. Muscle intracellular oxygenation during exercise: optimization for oxygen transport, metabolism, and adaptive change. Eur J Appl Physiol. 2012;112:1\u20138. https:\/\/doi.org\/10.1007\/s00421-011-1955-7.","journal-title":"Eur J Appl Physiol"},{"key":"2447_CR271","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1113\/jphysiol.2005.102327","volume":"571","author":"RS Richardson","year":"2006","unstructured":"Richardson RS, Duteil S, Wary C, Wray DW, Hoff J, Carlier PG. Human skeletal muscle intracellular oxygenation: the impact of ambient oxygen availability. J Physiol. 2006;571:415\u201324. https:\/\/doi.org\/10.1113\/jphysiol.2005.102327.","journal-title":"J Physiol"},{"key":"2447_CR272","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1152\/jappl.2001.91.6.2679","volume":"91","author":"RS Richardson","year":"2001","unstructured":"Richardson RS, Newcomer SC, Noyszewski EA. Skeletal muscle intracellular PO2 assessed by myoglobin desaturation: response to graded exercise. J Appl Physiol. 2001;91:2679\u201385. https:\/\/doi.org\/10.1152\/jappl.2001.91.6.2679.","journal-title":"J Appl Physiol"},{"key":"2447_CR273","doi-asserted-by":"publisher","first-page":"H906","DOI":"10.1152\/ajpheart.1987.252.5.H906","volume":"252","author":"TE Gayeski","year":"1987","unstructured":"Gayeski TE, Connett RJ, Honig CR. Minimum intracellular PO2 for maximum cytochrome turnover in red muscle in situ. Am J Physiol Heart Circ Physiol. 1987;252:H906\u201315. https:\/\/doi.org\/10.1152\/ajpheart.1987.252.5.H906.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2447_CR274","doi-asserted-by":"publisher","first-page":"H241","DOI":"10.1152\/ajpheart.2001.281.1.H241","volume":"281","author":"D Deveci","year":"2001","unstructured":"Deveci D, Marshall JM, Egginton S. Relationship between capillary angiogenesis, fiber type, and fiber size in chronic systemic hypoxia. Am J Physiol Heart Circ Physiol. 2001;281:H241\u201352. https:\/\/doi.org\/10.1152\/ajpheart.2001.281.1.H241.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2447_CR275","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1113\/eph8702377","volume":"87","author":"D Deveci","year":"2002","unstructured":"Deveci D, Marshall JM, Egginton S. Chronic hypoxia induces prolonged angiogenesis in skeletal muscles of rat. Exp Physiol. 2002;87:287\u201391. https:\/\/doi.org\/10.1113\/eph8702377.","journal-title":"Exp Physiol"},{"key":"2447_CR276","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1089\/ham.2008.1010","volume":"9","author":"E Breen","year":"2008","unstructured":"Breen E, Tang K, Olfert M, Knapp A, Wagner P. Skeletal muscle capillarity during hypoxia: VEGF and its activation. High Alt Med Biol. 2008;9:158\u201366. https:\/\/doi.org\/10.1089\/ham.2008.1010.","journal-title":"High Alt Med Biol"},{"key":"2447_CR277","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1113\/jphysiol.2006.113357","volume":"577","author":"M Milkiewicz","year":"2006","unstructured":"Milkiewicz M, Hudlicka O, Shiner R, Egginton S, Brown MD. Vascular endothelial growth factor mRNA and protein do not change in parallel during non-inflammatory skeletal muscle ischaemia in rat. J Physiol. 2006;577:671\u20138. https:\/\/doi.org\/10.1113\/jphysiol.2006.113357.","journal-title":"J Physiol"},{"key":"2447_CR278","doi-asserted-by":"publisher","first-page":"S315","DOI":"10.1249\/00005768-199209001-00002","volume":"24","author":"ER Eichner","year":"1992","unstructured":"Eichner ER. Sports anemia, iron supplements, and blood doping. Med Sci Sports Exerc. 1992;24:S315-318.","journal-title":"Med Sci Sports Exerc"},{"key":"2447_CR279","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1055\/s-2007-1021278","volume":"13","author":"LM Weight","year":"2008","unstructured":"Weight LM, Klein M, Noakes TD, Jacobs P. \u2018Sports anemia\u2019 - a real or apparent phenomenon in endurance-trained athletes? Int J Sports Med. 2008;13:344\u20137. https:\/\/doi.org\/10.1055\/s-2007-1021278.","journal-title":"Int J Sports Med"},{"key":"2447_CR280","volume":"49","author":"L Oberholzer","year":"2022","unstructured":"Oberholzer L, Lundby C. Hematological adaptations to endurance training. Proc Physiol Soc. 2022;49: SA04. https:\/\/www.physoc.org\/abstracts\/hematological-adaptations-to-endurance-training\/.","journal-title":"Proc Physiol Soc."},{"key":"2447_CR281","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1152\/jappl.1991.71.5.1914","volume":"71","author":"CM Gillen","year":"1991","unstructured":"Gillen CM, Lee R, Mack GW, Tomaselli CM, Nishiyasu T, Nadel ER. Plasma volume expansion in humans after a single intense exercise protocol. J Appl Physiol. 1991;71:1914\u201320. https:\/\/doi.org\/10.1152\/jappl.1991.71.5.1914.","journal-title":"J Appl Physiol"},{"key":"2447_CR282","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1152\/jappl.1998.85.2.484","volume":"85","author":"JM Hagberg","year":"1998","unstructured":"Hagberg JM, Goldberg AP, Lakatta L, O\u2019Connor FC, Becker LC, Lakatta EG, et al. Expanded blood volumes contribute to the increased cardiovascular performance of endurance-trained older men. J Appl Physiol. 1998;85:484\u20139. https:\/\/doi.org\/10.1152\/jappl.1998.85.2.484.","journal-title":"J Appl Physiol"},{"key":"2447_CR283","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1073\/pnas.0912924107","volume":"107","author":"B Schuler","year":"2010","unstructured":"Schuler B, Arras M, Keller S, Rettich A, Lundby C, Vogel J, et al. Optimal hematocrit for maximal exercise performance in acute and chronic erythropoietin-treated mice. Proc Natl Acad Sci U S A. 2010;107:419\u201323. https:\/\/doi.org\/10.1073\/pnas.0912924107.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2447_CR284","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0297553","volume":"19","author":"FG Pereira","year":"2024","unstructured":"Pereira FG, Greenfield AM, Kuennen M, Gillum TL. Exercise induced plasma volume expansion lowers cardiovascular strain during 15-km cycling time-trial in acute normobaric hypoxia. PLoS ONE. 2024;19:e0297553. https:\/\/doi.org\/10.1371\/journal.pone.0297553.","journal-title":"PLoS ONE"},{"key":"2447_CR285","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2165\/00007256-199213010-00004","volume":"13","author":"N Fellmann","year":"1992","unstructured":"Fellmann N. Hormonal and plasma volume alterations following endurance exercise. Sports Med. 1992;13:37\u201349. https:\/\/doi.org\/10.2165\/00007256-199213010-00004.","journal-title":"Sports Med"},{"key":"2447_CR286","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1097\/MAJ.0b013e318063c6e4","volume":"334","author":"VA Convertino","year":"2007","unstructured":"Convertino VA. Blood volume response to physical activity and inactivity. Am J Med Sci. 2007;334:72\u20139. https:\/\/doi.org\/10.1097\/MAJ.0b013e318063c6e4.","journal-title":"Am J Med Sci"},{"key":"2447_CR287","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2013.00332","author":"H Mairb\u00e4url","year":"2013","unstructured":"Mairb\u00e4url H. Red blood cells in sports: Effects of exercise and training on oxygen supply by red blood cells. Front Physiol. 2013. https:\/\/doi.org\/10.3389\/fphys.2013.00332.","journal-title":"Front Physiol"},{"issue":"1","key":"2447_CR288","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1152\/japplphysiol.00631.2001","volume":"94","author":"RD Telford","year":"2003","unstructured":"Telford RD, Sly GJ, Hahn AG, Cunningham RB, Bryant C, Smith JA. Footstrike is the major cause of hemolysis during running. J Appl Physiol. 2003;94(1):38\u201342. https:\/\/doi.org\/10.1152\/japplphysiol.00631.2001.","journal-title":"J Appl Physiol"},{"key":"2447_CR289","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1007\/s004210050502","volume":"79","author":"HJ Green","year":"1999","unstructured":"Green HJ, Carter S, Grant S, Tupling R, Coates G, Ali M. Vascular volumes and hematology in male and female runners and cyclists. Eur J Appl Physiol. 1999;79:244\u201350. https:\/\/doi.org\/10.1007\/s004210050502.","journal-title":"Eur J Appl Physiol"},{"key":"2447_CR290","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.125.013429","author":"WL Miller","year":"2025","unstructured":"Miller WL. Blood volume expansion: Can an adaptation of endurance training, altitude acclimatization, and pregnancy inform volume homeostasis in chronic heart failure and why does it matter? A viewpoint. Circ Heart Fail. 2025. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.125.013429.","journal-title":"Circ Heart Fail"},{"key":"2447_CR291","doi-asserted-by":"publisher","DOI":"10.1007\/s00508-024-02368-8","author":"C Ay","year":"2024","unstructured":"Ay C, Reinisch A. Gene therapy: principles, challenges and use in clinical practice. Wien Klin Wochenschr. 2024. https:\/\/doi.org\/10.1007\/s00508-024-02368-8.","journal-title":"Wien Klin Wochenschr"},{"key":"2447_CR292","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2023.1339189","volume":"11","author":"R Lopes","year":"2024","unstructured":"Lopes R, Prasad MK. Beyond the promise: evaluating and mitigating off-target effects in CRISPR gene editing for safer therapeutics. Front Bioeng Biotechnol. 2024;11:1339189. https:\/\/doi.org\/10.3389\/fbioe.2023.1339189.","journal-title":"Front Bioeng Biotechnol"},{"key":"2447_CR293","doi-asserted-by":"publisher","DOI":"10.3390\/ph16101416","volume":"16","author":"AY Shchaslyvyi","year":"2023","unstructured":"Shchaslyvyi AY, Antonenko SV, Tesliuk MG, Telegeev GD. Current state of human gene therapy: approved products and vectors. Pharmaceuticals Basel. 2023;16:1416. https:\/\/doi.org\/10.3390\/ph16101416.","journal-title":"Pharmaceuticals Basel"},{"key":"2447_CR294","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1002\/mus.1031","volume":"24","author":"AJ O\u2019Hara","year":"2001","unstructured":"O\u2019Hara AJ, Howell JM, Taplin RH, Fletcher S, Lloyd F, Kakulas B, et al. The spread of transgene expression at the site of gene construct injection. Muscle Nerve. 2001;24:488\u201395. https:\/\/doi.org\/10.1002\/mus.1031.","journal-title":"Muscle Nerve"},{"key":"2447_CR295","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/s41586-019-1912-x","volume":"577","author":"E Song","year":"2020","unstructured":"Song E, Mao T, Dong H, Boisserand LSB, Antila S, Bosenberg M, et al. VEGF-C-driven lymphatic drainage enables immunosurveillance of brain tumours. Nature. 2020;577:689\u201394. https:\/\/doi.org\/10.1038\/s41586-019-1912-x.","journal-title":"Nature"},{"key":"2447_CR296","doi-asserted-by":"publisher","unstructured":"Fernandez-Rodriguez R, Cuadrado-Castano S, Edwards A, Rogic A, Bykov Y, Mena I, et al. Lymphangiogenesis driven by VEGF-C reshapes tumor immune landscape and enables tumor eradication by viral immunotherapy. bioRxiv; 2025. p. 2025.08.27.672466. https:\/\/doi.org\/10.1101\/2025.08.27.672466","DOI":"10.1101\/2025.08.27.672466"},{"key":"2447_CR297","doi-asserted-by":"publisher","first-page":"4149","DOI":"10.4049\/jimmunol.152.8.4149","volume":"152","author":"AE Koch","year":"1994","unstructured":"Koch AE, Harlow LA, Haines GK, Amento EP, Unemori EN, Wong WL, et al. Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis. J Immunol. 1994;152:4149\u201356. https:\/\/doi.org\/10.4049\/jimmunol.152.8.4149.","journal-title":"J Immunol"},{"key":"2447_CR298","unstructured":"Duffy AM, Bouchier-Hayes DJ, Harmey J. Vascular Endothelial Growth Factor (VEGF) and its role in non-endothelial cells: autocrine signalling by VEGF. Madame Curie Biosci Database. Austin (TX): Landes Bioscience; 2013."},{"key":"2447_CR299","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1002\/scin.2008.5591740321","volume":"174","author":"P Barry","year":"2008","unstructured":"Barry P. Finding the golden genes: advances in gene therapy could tempt some athletes to enhance their genetic makeup, leading some researchers to work on detection methods just in case. Sci News. 2008;174:16\u201321. https:\/\/doi.org\/10.1002\/scin.2008.5591740321.","journal-title":"Sci News"},{"key":"2447_CR300","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1080\/17461391.2019.1695952","volume":"20","author":"RA Cantelmo","year":"2020","unstructured":"Cantelmo RA, Da Silva AP, Mendes\u2010Junior CT, Dorta DJ. Gene doping: present and future. Eur J Sport Sci. 2020;20:1093\u2013101. https:\/\/doi.org\/10.1080\/17461391.2019.1695952.","journal-title":"Eur J Sport Sci"},{"key":"2447_CR301","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41434-019-0091-6","volume":"26","author":"EN de Boer","year":"2019","unstructured":"de Boer EN, van der Wouden PE, Johansson LF, van Diemen CC, Haisma HJ. A next-generation sequencing method for gene doping detection that distinguishes low levels of plasmid DNA against a background of genomic DNA. Gene Ther. 2019;26:338\u201346. https:\/\/doi.org\/10.1038\/s41434-019-0091-6.","journal-title":"Gene Ther"},{"key":"2447_CR302","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adv7234","volume":"11","author":"J-Y Yi","year":"2025","unstructured":"Yi J-Y, Choi H, Kim M, Jeong Y, Hahn J-S, Son B, et al. High-throughput multiplexed gene and cell doping analysis through CRISPR-Cas12a system integrated with blood direct PCR. Sci Adv. 2025;11:eadv7234. https:\/\/doi.org\/10.1126\/sciadv.adv7234.","journal-title":"Sci Adv"},{"key":"2447_CR303","unstructured":"Beiter T, Zimmermann M, Fragasso A, Armeanu S, Lauer UM, Bitzer M, et al. Establishing a novel single-copy primer-internal intron-spanning PCR (spiPCR) procedure for the direct detection of gene doping. Exerc Immunol Rev. 2008;14:73\u201385. https:\/\/www.scopus.com\/inward\/record.uri?eid=2-s2.0-62849115532&partnerID=40&md5=1609faa7fe4350c9febf96df388811fb"},{"key":"2447_CR304","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/gt.2010.122","volume":"18","author":"T Beiter","year":"2011","unstructured":"Beiter T, Zimmermann M, Fragasso A, Hudemann J, Niess AM, Bitzer M, et al. Direct and long-term detection of gene doping in conventional blood samples. Gene Ther. 2011;18:225\u201331. https:\/\/doi.org\/10.1038\/gt.2010.122.","journal-title":"Gene Ther"},{"key":"2447_CR305","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-06677-4","author":"N Naumann","year":"2025","unstructured":"Naumann N, Do C, Vollmert C, Krajina M, Thomas A, Cheung HW, et al. Multiplex detection of seven transgenes for human gene doping analysis. Sci Rep. 2025. https:\/\/doi.org\/10.1038\/s41598-025-06677-4.","journal-title":"Sci Rep"},{"key":"2447_CR306","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s10456-023-09874-9","volume":"26","author":"K Rauniyar","year":"2023","unstructured":"Rauniyar K, Bokharaie H, Jeltsch M. Expansion and collapse of VEGF diversity in major clades of the animal kingdom. Angiogenesis. 2023;26:437\u201361. https:\/\/doi.org\/10.1007\/s10456-023-09874-9.","journal-title":"Angiogenesis"},{"key":"2447_CR307","doi-asserted-by":"publisher","first-page":"19310","DOI":"10.1074\/jbc.271.32.19310","volume":"271","author":"B Olofsson","year":"1996","unstructured":"Olofsson B, Pajusola K, von Euler G, Chilov D, Alitalo K, Eriksson U. Genomic organization of the mouse and human genes for vascular endothelial growth factor B (VEGF-B) and characterization of a second splice isoform. J Biol Chem. 1996;271:19310\u20137. https:\/\/doi.org\/10.1074\/jbc.271.32.19310.","journal-title":"J Biol Chem"},{"key":"2447_CR308","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/sj.gt.3301459","volume":"8","author":"N Cheshenko","year":"2001","unstructured":"Cheshenko N, Krougliak N, Eisensmith RC, Krougliak VA. A novel system for the production of fully deleted adenovirus vectors that does not require helper adenovirus. Gene Ther. 2001;8:846\u201354. https:\/\/doi.org\/10.1038\/sj.gt.3301459.","journal-title":"Gene Ther"},{"key":"2447_CR309","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1126\/science.1058040","volume":"291","author":"JC Venter","year":"2001","unstructured":"Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, Sutton GG, et al. The sequence of the human genome. Science. 2001;291:1304\u201351. https:\/\/doi.org\/10.1126\/science.1058040.","journal-title":"Science"},{"key":"2447_CR310","unstructured":"Scherer S. Gene Structure. Guide Hum Genome. Cold Spring Harbor Laboratory Press; 2010. https:\/\/www.cshlp.org\/ghg5_all\/section\/gene.shtml. Accessed 19 Aug 2025"},{"key":"2447_CR311","unstructured":"Rohrmann GF. DNA replication and genome processing. Baculovirus Mol Biol Internet 4th Ed. National Center for Biotechnology Information (US); 2019. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK543453\/. Accessed 19 Aug 2025"},{"key":"2447_CR312","unstructured":"R&D Systems. Human VEGF Quantikine ELISA Kit. https:\/\/www.rndsystems.com\/products\/human-vegf-quantikine-elisa-kit_dve00. Accessed 14 May 2025"},{"key":"2447_CR313","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10225452","volume":"10","author":"GE B\u0119dkowska","year":"2021","unstructured":"B\u0119dkowska GE, Gacuta E, Zbucka-Kr\u0119towska M, \u0141awicki P, Szmitkowski M, Lemancewicz A, et al. Plasma levels and diagnostic utility of VEGF in a three-year follow-up of patients with breast cancer. J Clin Med. 2021;10:5452. https:\/\/doi.org\/10.3390\/jcm10225452.","journal-title":"J Clin Med"},{"key":"2447_CR314","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0184234","volume":"12","author":"M Hanefeld","year":"2017","unstructured":"Hanefeld M, Engelmann K, Appelt D, Sandner D, Weigmann I, Ganz X, et al. Intra-individual variability and circadian rhythm of vascular endothelial growth factors in subjects with normal glucose tolerance and type 2 diabetes. PLoS ONE. 2017;12:e0184234. https:\/\/doi.org\/10.1371\/journal.pone.0184234.","journal-title":"PLoS ONE"},{"key":"2447_CR315","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-024-01722-w","volume":"29","author":"T Nakamizo","year":"2024","unstructured":"Nakamizo T, Cologne J, Kishi T, Takahashi T, Inoue M, Ryukaku H, et al. Reliability, stability during long-term storage, and intra-individual variation of circulating levels of osteopontin, osteoprotegerin, vascular endothelial growth factor-A, and interleukin-17A. Eur J Med Res. 2024;29:133. https:\/\/doi.org\/10.1186\/s40001-024-01722-w.","journal-title":"Eur J Med Res"},{"key":"2447_CR316","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1000622","volume":"5","author":"MO Stefanini","year":"2009","unstructured":"Stefanini MO, Wu FTH, Gabhann FM, Popel AS. The presence of VEGF receptors on the luminal surface of endothelial cells affects VEGF distribution and VEGF signaling. PLoS Comput Biol. 2009;5:e1000622. https:\/\/doi.org\/10.1371\/journal.pcbi.1000622.","journal-title":"PLoS Comput Biol"},{"key":"2447_CR317","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s00424-022-02714-7","volume":"474","author":"SL Dahl","year":"2022","unstructured":"Dahl SL, Bapst AM, Khodo SN, Scholz CC, Wenger RH. Fount, fate, features, and function of renal erythropoietin-producing cells. Pflugers Arch Eur J Physiol. 2022;474:783\u201397. https:\/\/doi.org\/10.1007\/s00424-022-02714-7.","journal-title":"Pflugers Arch Eur J Physiol"},{"key":"2447_CR318","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.1101\/gad.242002","volume":"16","author":"C Ruhrberg","year":"2002","unstructured":"Ruhrberg C, Gerhardt H, Golding M, Watson R, Ioannidou S, Fujisawa H, et al. Spatially restricted patterning cues provided by heparin-binding VEGF-A control blood vessel branching morphogenesis. Genes Dev. 2002;16:2684\u201398. https:\/\/doi.org\/10.1101\/gad.242002.","journal-title":"Genes Dev"},{"key":"2447_CR319","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1083\/jcb.200302047","volume":"161","author":"H Gerhardt","year":"2003","unstructured":"Gerhardt H, Golding M, Fruttiger M, Ruhrberg C, Lundkvist A, Abramsson A, et al. VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J Cell Biol. 2003;161:1163\u201377. https:\/\/doi.org\/10.1083\/jcb.200302047.","journal-title":"J Cell Biol"},{"key":"2447_CR320","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1123\/ijspp.2019-0643","volume":"15","author":"S Iljukov","year":"2020","unstructured":"Iljukov S, Kauppi J-P, Uusitalo ALT, Peltonen JE, Schumacher YO. Association between implementation of the athlete biological passport and female elite runners\u2019 performance. Int J Sports Physiol Perform. 2020;15:1231\u20136. https:\/\/doi.org\/10.1123\/ijspp.2019-0643.","journal-title":"Int J Sports Physiol Perform"},{"key":"2447_CR321","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1210\/clinem\/dgab799","volume":"107","author":"T Equey","year":"2022","unstructured":"Equey T, Pastor A, de la Torre FR, Thomas A, Giraud S, Thevis M, et al. Application of the athlete biological passport approach to the detection of growth hormone doping. J Clin Endocrinol Metab. 2022;107:649\u201359. https:\/\/doi.org\/10.1210\/clinem\/dgab799.","journal-title":"J Clin Endocrinol Metab"},{"key":"2447_CR322","doi-asserted-by":"publisher","DOI":"10.1111\/micc.12683","volume":"28","author":"M Guerraty","year":"2021","unstructured":"Guerraty M, Bhargava A, Senarathna J, Mendelson AA, Pathak AP. Advances in translational imaging of the microcirculation. Microcirc N Y N 1994. 2021;28:e12683. https:\/\/doi.org\/10.1111\/micc.12683.","journal-title":"Microcirc N Y N 1994"},{"key":"2447_CR323","doi-asserted-by":"publisher","first-page":"189","DOI":"10.2174\/2211536608666190117170317","volume":"8","author":"A Marchand","year":"2019","unstructured":"Marchand A, Roulland I, Semence F, Schr\u00f6der K, Domergue V, Audran M. Detection of hypoxia-regulated microRNAs in blood as potential biomarkers of HIF stabilizer Molidustat. MicroRNA. 2019;8:189\u201397. https:\/\/doi.org\/10.2174\/2211536608666190117170317.","journal-title":"MicroRNA"},{"key":"2447_CR324","doi-asserted-by":"publisher","unstructured":"Hua Z, Lv Q, Ye W, Wong C-KA, Cai G, Gu D, et al. MiRNA-Directed Regulation of VEGF and Other Angiogenic Factors under Hypoxia. Valcarcel J, editor. PLoS One. 2006;1:e116. https:\/\/doi.org\/10.1371\/journal.pone.0000116","DOI":"10.1371\/journal.pone.0000116"},{"key":"2447_CR325","doi-asserted-by":"publisher","first-page":"24","DOI":"10.2478\/aiht-2024-75-3793","volume":"75","author":"D Drag\u010devi\u0107","year":"2024","unstructured":"Drag\u010devi\u0107 D, Pand\u017ei\u0107 Jak\u0161i\u0107 V, Jak\u0161i\u0107 O. Athlete biological passport: longitudinal biomarkers and statistics in the fight against doping. Arch Ind Hyg Toxicol. 2024;75:24\u201331. https:\/\/doi.org\/10.2478\/aiht-2024-75-3793.","journal-title":"Arch Ind Hyg Toxicol"},{"key":"2447_CR326","doi-asserted-by":"publisher","first-page":"4495","DOI":"10.1073\/pnas.90.10.4495","volume":"90","author":"A de la Chapelle","year":"1993","unstructured":"de la Chapelle A, Tr\u00e4skelin AL, Juvonen E. Truncated erythropoietin receptor causes dominantly inherited benign human erythrocytosis. Proc Natl Acad Sci U S A. 1993;90:4495\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2447_CR327","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1038\/s41551-024-01222-6","volume":"8","author":"SE Luna","year":"2024","unstructured":"Luna SE, Camarena J, Hampton JP, Majeti KR, Charlesworth CT, Soupene E, et al. Enhancement of erythropoietic output by Cas9-mediated insertion of a natural variant in haematopoietic stem and progenitor cells. Nat Biomed Eng. 2024;8:1540\u201352. https:\/\/doi.org\/10.1038\/s41551-024-01222-6.","journal-title":"Nat Biomed Eng"},{"key":"2447_CR328","doi-asserted-by":"publisher","DOI":"10.3389\/fragi.2021.802407","volume":"2","author":"F Manders","year":"2021","unstructured":"Manders F, van Boxtel R, Middelkamp S. The dynamics of somatic mutagenesis during life in humans. Front Aging. 2021;2:802407. https:\/\/doi.org\/10.3389\/fragi.2021.802407.","journal-title":"Front Aging"},{"key":"2447_CR329","doi-asserted-by":"publisher","first-page":"15","DOI":"10.4161\/cbt.7.1.5337","volume":"7","author":"N Denduluri","year":"2008","unstructured":"Denduluri N, Yang SX, Berman AW, Nguyen D, Liewehr DJ, Steinberg SM, et al. Circulating biomarkers of bevacizumab activity in patients with breast cancer. Cancer Biol Ther. 2008;7:15\u201320. https:\/\/doi.org\/10.4161\/cbt.7.1.5337.","journal-title":"Cancer Biol Ther"},{"key":"2447_CR330","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1158\/1078-0432.CCR-12-2535","volume":"19","author":"PS Hegde","year":"2013","unstructured":"Hegde PS, Jubb AM, Chen D, Li NF, Meng YG, Bernaards C, et al. Predictive impact of circulating vascular endothelial growth factor in four phase III trials evaluating bevacizumab. Clin Cancer Res. 2013;19:929\u201337. https:\/\/doi.org\/10.1158\/1078-0432.CCR-12-2535.","journal-title":"Clin Cancer Res"},{"key":"2447_CR331","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1038\/s41467-025-58186-7","volume":"16","author":"K Tanaka","year":"2025","unstructured":"Tanaka K, Sugisaka J, Shiraishi Y, Watanabe Y, Daga H, Azuma K, et al. Serum VEGF-A as a biomarker for the addition of bevacizumab to chemo-immunotherapy in metastatic NSCLC. Nat Commun. 2025;16:2825. https:\/\/doi.org\/10.1038\/s41467-025-58186-7.","journal-title":"Nat Commun"},{"key":"2447_CR332","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2015.00167","author":"T Souma","year":"2015","unstructured":"Souma T, Suzuki N, Yamamoto M. Renal erythropoietin-producing cells in health and disease. Front Physiol. 2015. https:\/\/doi.org\/10.3389\/fphys.2015.00167.","journal-title":"Front Physiol"},{"key":"2447_CR333","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1111\/j.1524-475X.2011.00740.x","volume":"19","author":"S Roy","year":"2011","unstructured":"Roy S, Driggs J, Elgharably H, Biswas S, Findley M, Khanna S, et al. Platelet rich fibrin matrix improves wound angiogenesis via inducing endothelial cell proliferation. Wound Repair Regen. 2011;19:753\u201366. https:\/\/doi.org\/10.1111\/j.1524-475X.2011.00740.x.","journal-title":"Wound Repair Regen"},{"key":"2447_CR334","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1083\/jcb.200703052","volume":"179","author":"P Mineur","year":"2007","unstructured":"Mineur P, Colige AC, Deroanne ChristopheF, Dubail J, Kesteloot F, Habraken Y, et al. Newly identified biologically active and proteolysis-resistant VEGF-A isoform VEGF111 is induced by genotoxic agents. J Cell Biol. 2007;179:1261\u201373. https:\/\/doi.org\/10.1083\/jcb.200703052.","journal-title":"J Cell Biol"},{"key":"2447_CR335","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1038\/s41591-023-02322-7","volume":"29","author":"A Abedini","year":"2023","unstructured":"Abedini A, Kl\u00f6tzer KA, Susztak K. Unmasking the elusive erythropoietin-producing \u2018Norn\u2019 cell. Nat Med. 2023;29:1064\u20135. https:\/\/doi.org\/10.1038\/s41591-023-02322-7.","journal-title":"Nat Med"},{"key":"2447_CR336","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/8379","volume":"5","author":"P Carmeliet","year":"1999","unstructured":"Carmeliet P, Ng Y-S, Nuyens D, Theilmeier G, Brusselmans K, Cornelissen I, et al. Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF 164 and VEGF 188. Nat Med. 1999;5:495\u2013502. https:\/\/doi.org\/10.1038\/8379.","journal-title":"Nat Med"},{"key":"2447_CR337","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1080\/10739680902997333","volume":"16","author":"J Woolard","year":"2009","unstructured":"Woolard J, Bevan HS, Harper SJ, Bates DO. Molecular diversity of VEGF-A as a regulator of its biological activity. Microcirculation. 2009;16:572\u201392. https:\/\/doi.org\/10.1080\/10739680902997333.","journal-title":"Microcirculation"},{"key":"2447_CR338","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/ncb2679","volume":"15","author":"M Nakayama","year":"2013","unstructured":"Nakayama M, Nakayama A, van Lessen M, Yamamoto H, Hoffmann S, Drexler HCA, et al. Spatial regulation of VEGF receptor endocytosis in angiogenesis. Nat Cell Biol. 2013;15:249\u201360. https:\/\/doi.org\/10.1038\/ncb2679.","journal-title":"Nat Cell Biol"},{"key":"2447_CR339","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19051378","volume":"19","author":"S Dragoni","year":"2018","unstructured":"Dragoni S, Turowski P. Polarised VEGFA signalling at vascular blood\u2013neural barriers. Int J Mol Sci. 2018;19:1378. https:\/\/doi.org\/10.3390\/ijms19051378.","journal-title":"Int J Mol Sci"},{"key":"2447_CR340","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1158\/1078-0432.CCR-22-1366","volume":"29","author":"SA Patel","year":"2023","unstructured":"Patel SA, Nilsson MB, Le X, Cascone T, Jain RK, Heymach JV. Molecular mechanisms and future implications of VEGF\/VEGFR in cancer therapy. Clin Cancer Res. 2023;29:30\u20139. https:\/\/doi.org\/10.1158\/1078-0432.CCR-22-1366.","journal-title":"Clin Cancer Res"},{"key":"2447_CR341","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1158\/1078-0432.CCR-12-3585","volume":"19","author":"R Gyanchandani","year":"2013","unstructured":"Gyanchandani R, Kim S. Predictive biomarkers to anti-VEGF therapy: progress towards an elusive goal. Clin Cancer Res. 2013;19:755\u20137. https:\/\/doi.org\/10.1158\/1078-0432.CCR-12-3585.","journal-title":"Clin Cancer Res"},{"key":"2447_CR342","doi-asserted-by":"publisher","DOI":"10.1177\/10732748241270589","volume":"31","author":"W Zhao","year":"2024","unstructured":"Zhao W, Jiang J. Advances in predictive biomarkers for anti-angiogenic therapy in non-small cell lung cancer. Cancer Control. 2024;31:10732748241270589. https:\/\/doi.org\/10.1177\/10732748241270589.","journal-title":"Cancer Control"},{"key":"2447_CR343","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.devcel.2014.06.027","volume":"30","author":"N Hudson","year":"2014","unstructured":"Hudson N, Powner MB, Sarker MH, Burgoyne T, Campbell M, Ockrim ZK, et al. Differential Apicobasal VEGF signaling at vascular blood-neural barriers. Dev Cell. 2014;30:541\u201352. https:\/\/doi.org\/10.1016\/j.devcel.2014.06.027.","journal-title":"Dev Cell"},{"key":"2447_CR344","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/72212","volume":"6","author":"RK Jain","year":"2000","unstructured":"Jain RK, Munn LL. Leaky vessels? Call Ang1! Nat Med. 2000;6:131\u20132. https:\/\/doi.org\/10.1038\/72212.","journal-title":"Nat Med"},{"key":"2447_CR345","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.devcel.2007.10.019","volume":"14","author":"J Gavard","year":"2008","unstructured":"Gavard J, Patel V, Gutkind JS. Angiopoietin-1 prevents VEGF-induced endothelial permeability by sequestering Src through mDia. Dev Cell. 2008;14:25\u201336. https:\/\/doi.org\/10.1016\/j.devcel.2007.10.019.","journal-title":"Dev Cell"},{"key":"2447_CR346","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1161\/hy0302.105398","volume":"39","author":"R Yang","year":"2002","unstructured":"Yang R, Ogasawara AK, Zioncheck TF, Ren Z, He G-W, DeGuzman GG, et al. Exaggerated hypotensive effect of Vascular Endothelial Growth Factor in Spontaneously Hypertensive Rats. Hypertension. 2002;39:815\u201320. https:\/\/doi.org\/10.1161\/hy0302.105398.","journal-title":"Hypertension"},{"key":"2447_CR347","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-85693-6","volume":"11","author":"JP Waller","year":"2021","unstructured":"Waller JP, Burke SP, Engel J, Chade AR, Bidwell GL. A dose-escalating toxicology study of the candidate biologic ELP-VEGF. Sci Rep. 2021;11:6216. https:\/\/doi.org\/10.1038\/s41598-021-85693-6.","journal-title":"Sci Rep"},{"key":"2447_CR348","doi-asserted-by":"crossref","unstructured":"Kataru RP, Baik JE, Park HJ, Ly CL, Shin J, Schwartz N, et al. Lymphatic-specific intracellular modulation of receptor tyrosine kinase signaling improves lymphatic growth and function. Sci Signal. 2021;","DOI":"10.1126\/scisignal.abc0836"},{"key":"2447_CR349","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jbior.2014.09.012","volume":"57","author":"L Spinelli","year":"2015","unstructured":"Spinelli L, Lindsay YE, Leslie NR. PTEN inhibitors: an evaluation of current compounds. Adv Biol Regul. 2015;57:102\u201311. https:\/\/doi.org\/10.1016\/j.jbior.2014.09.012.","journal-title":"Adv Biol Regul"},{"key":"2447_CR350","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/s41392-024-01899-w","volume":"9","author":"C Tomuleasa","year":"2024","unstructured":"Tomuleasa C, Tigu A-B, Munteanu R, Moldovan C-S, Kegyes D, Onaciu A, et al. Therapeutic advances of targeting receptor tyrosine kinases in cancer. Signal Transduct Target Ther. 2024;9:201. https:\/\/doi.org\/10.1038\/s41392-024-01899-w.","journal-title":"Signal Transduct Target Ther"},{"key":"2447_CR351","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms2683","volume":"4","author":"M Hayashi","year":"2013","unstructured":"Hayashi M, Majumdar A, Li X, Adler J, Sun Z, Vertuani S, et al. VE-PTP regulates VEGFR2 activity in stalk cells to establish endothelial cell polarity and lumen formation. Nat Commun. 2013;4:1672. https:\/\/doi.org\/10.1038\/ncomms2683.","journal-title":"Nat Commun"},{"key":"2447_CR352","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1161\/CIRCULATIONAHA.114.009683","volume":"130","author":"AA Lanahan","year":"2014","unstructured":"Lanahan AA, Lech D, Dubrac A, Zhang J, Zhuang ZW, Eichmann A, et al. PTP1b is a physiologic regulator of Vascular Endothelial Growth Factor signaling in endothelial cells. Circulation. 2014;130:902\u20139. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.114.009683.","journal-title":"Circulation"},{"key":"2447_CR353","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23137027","volume":"23","author":"R Liu","year":"2022","unstructured":"Liu R, Mathieu C, Berthelet J, Zhang W, Dupret J-M, Rodrigues Lima F. Human Protein Tyrosine Phosphatase 1B (PTP1B): from structure to clinical inhibitor perspectives. Int J Mol Sci. 2022;23:7027. https:\/\/doi.org\/10.3390\/ijms23137027.","journal-title":"Int J Mol Sci"},{"key":"2447_CR354","doi-asserted-by":"publisher","first-page":"4564","DOI":"10.1172\/JCI74527","volume":"124","author":"J Shen","year":"2014","unstructured":"Shen J, Frye M, Lee BL, Reinardy JL, McClung JM, Ding K, et al. Targeting VE-PTP activates TIE2 and stabilizes the ocular vasculature. J Clin Invest. 2014;124:4564\u201376. https:\/\/doi.org\/10.1172\/JCI74527.","journal-title":"J Clin Invest"},{"key":"2447_CR355","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1249\/MSS.0000000000002330","volume":"52","author":"WFJ Schmidt","year":"2020","unstructured":"Schmidt WFJ, Hoffmeister T, Haupt S, Schwenke D, Wachsmuth NB, Byrnes WC. Chronic exposure to low-dose Carbon Monoxide alters hemoglobin mass and V\u02d9O2max. Med Sci Sports Exerc. 2020;52:1879. https:\/\/doi.org\/10.1249\/MSS.0000000000002330.","journal-title":"Med Sci Sports Exerc"},{"key":"2447_CR356","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1021\/acs.jmedchem.3c01932","volume":"67","author":"J Xu","year":"2024","unstructured":"Xu J, Ding X, Fu Y, Meng Q, Wang L, Zhang M, et al. Discovery of novel and potent Prolyl Hydroxylase Domain-Containing Protein (PHD) inhibitors for the treatment of anemia. J Med Chem. 2024;67:1393\u2013405. https:\/\/doi.org\/10.1021\/acs.jmedchem.3c01932.","journal-title":"J Med Chem"},{"key":"2447_CR357","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1056\/NEJM197703172961101","volume":"296","author":"EAJ Mortimer","year":"1977","unstructured":"Mortimer EAJ, Monson RR, MacMahon B. Reduction in mortality from coronary heart disease in men residing at high altitude. N Engl J Med. 1977;296:581\u20135. https:\/\/doi.org\/10.1056\/NEJM197703172961101.","journal-title":"N Engl J Med"},{"key":"2447_CR358","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/s0008-6363(02)00456-x","volume":"55","author":"J Neck\u00e1r","year":"2002","unstructured":"Neck\u00e1r J, Sz\u00e1rszoi O, Koten L, Papousek F, Ost\u2019\u00e1dal B, Grover GJ, et al. Effects of mitochondrial K(ATP) modulators on cardioprotection induced by chronic high altitude hypoxia in rats. Cardiovasc Res. 2002;55:567\u201375. https:\/\/doi.org\/10.1016\/s0008-6363(02)00456-x.","journal-title":"Cardiovasc Res"},{"key":"2447_CR359","doi-asserted-by":"publisher","DOI":"10.5772\/65354","author":"J Ke","year":"2017","unstructured":"Ke J, Wang L, Xiao D. Cardiovascular adaptation to high-altitude hypoxia. Hypoxia Hum Dis. 2017. https:\/\/doi.org\/10.5772\/65354.","journal-title":"Hypoxia Hum Dis."},{"key":"2447_CR360","doi-asserted-by":"publisher","first-page":"16177","DOI":"10.1073\/pnas.1909002116","volume":"116","author":"M Stembridge","year":"2019","unstructured":"Stembridge M, Williams AM, Gasho C, Dawkins TG, Drane A, Villafuerte FC, et al. The overlooked significance of plasma volume for successful adaptation to high altitude in Sherpa and Andean natives. Proc Natl Acad Sci U S A. 2019;116:16177\u20139. https:\/\/doi.org\/10.1073\/pnas.1909002116.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2447_CR361","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2019.00069","author":"K Pinckard","year":"2019","unstructured":"Pinckard K, Baskin KK, Stanford KI. Effects of exercise to improve cardiovascular health. Front Cardiovasc Med. 2019. https:\/\/doi.org\/10.3389\/fcvm.2019.00069.","journal-title":"Front Cardiovasc Med"},{"key":"2447_CR362","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s40279-017-0765-4","volume":"48","author":"R Ulrich","year":"2018","unstructured":"Ulrich R, Pope HG, Cl\u00e9ret L, Petr\u00f3czi A, Nepusz T, Schaffer J, et al. Doping in two elite athletics competitions assessed by randomized-response surveys. Sports Med. 2018;48:211\u20139. https:\/\/doi.org\/10.1007\/s40279-017-0765-4.","journal-title":"Sports Med"}],"container-title":["Sports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40279-026-02447-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40279-026-02447-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40279-026-02447-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T05:01:59Z","timestamp":1787461319000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40279-026-02447-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,21]]},"references-count":362,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["2447"],"URL":"https:\/\/doi.org\/10.1007\/s40279-026-02447-y","relation":{},"ISSN":["0112-1642","1179-2035"],"issn-type":[{"value":"0112-1642","type":"print"},{"value":"1179-2035","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,21]]},"assertion":[{"value":"17 April 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"SS was supported by the Finnish Ministry of Education and Culture (EDUFI, OPH-4300-2024), and JK received support from the Research Council of Finland (#337120, GeneCellNano).","order":1,"name":"Ethics","label":"Funding","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"S.L. performed the initial literature search and wrote the first draft of the manuscript. S.L. and M.J. prepared the figures. S.L., S.S., and M.J. performed literature research, reference management, and contributed to and expanded individual sections of the manuscript. S.I. provided key insights into the current doping landscape and conceptual guidance throughout the manuscript's development. J.K. contributed through editing and, together with M.J., coordinated and supervised the work. All authors read and approved the final version of the article.","order":2,"name":"Ethics","label":"Author Contributions","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Sofie Lehto is an active kickboxer and accredited referee and judge for the Finnish Kickboxing Federation (\n                      Suomen Potkunyrkkeilyliitto\n                      ). Sergei Iljukov is a specialist in sports and exercise medicine at\n                      Terveystalo\n                      , the largest Finnish private healthcare provider. He also serves as a consulting doctor for several amateur and professional sports teams in Finland. In addition to his clinical work, Sergei Iljukov is a researcher in anti-doping and athletic performance. He is a member of the Elite Sports Working Group of the Finnish Ministry of Education and Culture and the Vice-President of the Finnish Society of Sports and Exercise Medicine. Michael Jeltsch has participated in competitive long-distance running events and has a personal interest in the sport. Setareh Sima and Jaana K\u00fcnnapuu have no relevant financial or non-financial interests to disclose.","order":3,"name":"Ethics","label":"Conflicts of Interest\/Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Availability of Data and Material","group":{"name":"EthicsHeading","label":"Declarations"}}]}}